Investigations on Rab31's Role in EGFR Trafficking and Neural Progenitor Cell Differentiation Towards Astroglia by CHRISTELLE CHUA EN LIN
 
 
   
INVESTIGATIONS ON RAB31’S ROLE IN  
EGFR TRAFFICKING AND NEURAL PROGENITOR  




CHRISTELLE CHUA EN LIN 





A THESIS SUBMITTED FOR  
THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
NUS GRADUATE SCHOOL FOR INTEGRATIVE 
SCIENCES AND ENGINEERING 
 









I hereby declare that this thesis is my original work and it has been written by me in 
its entirety. I have duly acknowledged the sources of information which have been 
used in the thesis.  
 














I would like to thank my supervisor, A/Prof Tang Bor Luen, for his unwavering 
support and mentorship through the course of my studies.   
 
 
I would also like to acknowledge our past and present lab members, for their expertise 
and assistance which have contributed to my research. 
 
 





Table of Contents 
Summary ........................................................................................................................................ v 
List of Tables ............................................................................................................................... vii 
List of Figures .............................................................................................................................. vii 
List of Symbols ............................................................................................................................. xi 
List of Abbreviations .................................................................................................................. xii 
1. Introduction ............................................................................................................................... 1 
1.1 Overview of Rab GTPases ........................................................................................ 1 
1.1.1 Rab-interacting proteins and how they aid in achieving specificity in Rab 
function ................................................................................................................... 4 
1.1.2 Localisation of Rab proteins to target membranes ........................................ 8 
1.1.3 Rab cascades and crosstalk between Rabs and their interacting proteins ... 15 
1.2 Overview of the Rab5 subfamily ............................................................................ 18 
1.2.1 The endocytic system intersects with cellular signalling ............................ 18 
1.2.2 Rab5 subfamily members and the EGFR trafficking pathway .................... 20 
1.2.3 Other Rabs implicated in the EGFR trafficking pathway ........................... 25 
1.2.4 Introduction to Rab31 .................................................................................. 25 
1.3 Physiological and pathophysiological activities of Rabs ........................................ 29 
1.3.1 Role of Rabs in cancer ................................................................................. 30 
1.3.2 Role of Rabs in the nervous system ............................................................ 31 
1.4 Rationale for studies reported in this thesis ............................................................ 34 
2. Materials and Methods ........................................................................................................... 36 
2.1 Gene constructs ....................................................................................................... 36 
2.2 Antibodies ............................................................................................................... 37 
2.3 Cell culture and transfection ................................................................................... 38 
2.4 Primary mouse neural progenitor cell (NPC) culture .............................................. 38 
 iii 
 
2.5 Expression silencing ................................................................................................ 39 
2.6 Retroviral transduction ............................................................................................ 40 
2.7 Reverse-transcription and real-time PCR ................................................................ 41 
2.8 EGF pulse-chase experiments ................................................................................. 42 
2.9 Collection of cell lysate and Western blot .............................................................. 43 
2.10 Immunocytochemistry, immunohistochemistry, and immunofluorescence 
microscopy .................................................................................................................... 43 
2.11 Live-cell imaging .................................................................................................. 44 
2.12 Flow cytometry ..................................................................................................... 44 
2.13 Glycerol gradient sedimentation ........................................................................... 44 
2.14 Co-immunoprecipitation ....................................................................................... 45 
2.15 GST affinity pulldown assay ................................................................................. 45 
2.16 Statistical analysis ................................................................................................. 45 
3. Domains and interactions responsible for the subcellular localisation of Rab31 ............. 46 
3.1 Chapter Introduction: Localisation of Rab proteins to distinct membranes ............ 46 
3.2 Results: Dependence of Rab31 subcellular localisation on functional domains ..... 47 
3.3 Results: Dependence of Rab31 subcellular localisation on interacting proteins..... 51 
3.4 Chapter Discussion: Factors influencing Rab31 subcellular localisation ............... 57 
4. Role of Rab31 in EGFR trafficking ....................................................................................... 61 
4.1 Chapter Introduction: Rab proteins in trafficking of cell surface receptor EGFR .. 61 
4.2 Results: Rab31 in endocytosis and degradation of EGFR ...................................... 62 
4.3 Results: Rab31 in recycling of EGFR ..................................................................... 85 
4.4 Chapter Discussion: Rab31 plays a role in early-to-late endosome trafficking of 
ligand-bound EGFR through a trafficking complex...................................................... 87 
5. The role of Rab31-interacting proteins in Rab31-mediated EGFR trafficking ................ 89 
5.1 Chapter Introduction: Potential Rab31-interacting proteins in an EGFR-
trafficking complex ....................................................................................................... 89 
 iv 
 
5.2 Results: Role of EEA1 in Rab31-mediated EGFR trafficking ................................ 90 
5.3 Results: Role of GAPex5 in Rab31-mediated EGFR trafficking ............................ 97 
5.4 Results: RIN3 mediates a separate trafficking role of Rab31 ............................... 102 
5.5 Chapter Discussion: Interacting proteins mediate different roles of Rab31 ......... 107 
6. Physiological role of Rab31 in the central nervous system ............................................... 110 
6.1 Chapter Introduction: Astrocytic cells and neurogenesis in the brain .................. 110 
6.2 Results: Rab31 in the adult rodent brain ............................................................... 112 
6.3 Results: Rab31 in neural progenitor cells ............................................................. 117 
6.4 Chapter Discussion: Possible role of Rab31 in NPCs and astrocytes ................... 135 
7. Conclusion and future perspectives .................................................................................... 139 
7.1 General conclusions .............................................................................................. 139 
7.2 Applications and implications of our findings ...................................................... 144 
References .................................................................................................................................. 150 
Appendix 1 – Plasmid vectors .................................................................................................. 165 





Rab31 is a member of the Rab5 subfamily of Rab GTPases, which play a role in 
trafficking of endocytic lumenal and membrane cargo. We have investigated factors 
influencing Rab31’s subcellular localisation and found that Rab31 functional domains 
and interacting partners are both important to its localisation at the trans-Golgi 
network (TGN). We also investigated Rab31’s role in the trafficking of ligand-bound 
epidermal growth factor (EGF) receptor (EGFR) internalised through receptor-
mediated endocytosis, which has hitherto not been explored. We found that depletion 
of Rab31 inhibits, while Rab31 overexpression enhances, EGFR trafficking to the late 
endosomes. Rab31 was found to interact with EGFR by co-immunoprecipitation and 
affinity pulldown analyses, and the primarily TGN-localised Rab31 has increased 
colocalisation with EGFR on endosomes at 30 min after pulsing with EGF. We found 
that loss of early endosome antigen 1 (EEA1), a Rab31 effector, reduced the 
interaction between Rab31 and EGFR, and abrogated the effect of Rab31 
overexpression on the trafficking of EGFR. Likewise, loss of GAPex5, a Rab31 
guanine nucleotide exchange factor (GEF) that has a role in ubiquitination and 
degradation of EGFR, reduced the interaction of Rab31 with EGFR and its effect on 
EGFR trafficking. Taken together, our results suggest that Rab31 is an important 
regulator of endocytic trafficking of EGFR, and functions in an EGFR trafficking 
complex that requires EEA1 and GAPex5 for its formation. To explore the 
physiological role of Rab31 which is highly expressed in radial glia and mature 
astrocytes, we looked at Rab31 in neural progenitor cells (NPCs) both in the 
neurogenic regions of the adult mouse brain and in culture. NPCs expressed high 
levels of Rab31, but when NPCs were induced to differentiate, Rab31 levels dipped 
then reappeared in a subset of the glial fibrillary acidic protein (GFAP)-positive 
 vi 
 
astrocyte population. Depletion of Rab31 appeared to decrease the percentage of 
GFAP-positive cells obtained. This suggests that Rab31 plays a role in the 
differentiation of neural progenitor cells of the brain. This may be, in part, due to its 
role in EGFR trafficking. Results presented in this thesis have implications for both 
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1. Introduction  
1.1 Overview of Rab GTPases 
GTPases are GTP-activated regulatory proteins with an intrinsic enzymatic 
activity that hydrolyses guanosine triphosphate (GTP) to guanosine diphosphate 
(GDP).  The superfamily of small (20-35 kDa) GTPases include Ras, Rho, and Rab, 
and these function as molecular switches in the cell, with the latter playing critical 
roles in membrane transport (Colicelli, 2004). Rabs (Ras-related protein in brain) are 
found in all eukaryotes, including yeast, plants and mammals (Pfeffer, 2005) and the 
human genome encodes over 60 different Rab and Rab-like genes (Segev, 2001; 
Hutagalung and Novick, 2011; Klöpper et al., 2012).   
 Rab proteins are peripheral membrane proteins. They have a hydrophobic 
prenyl (geranyl-geranyl) group attached to two terminal cysteines at the C-terminus. 
When the Rab GDP dissociation inhibitor (GDI) is bound to the prenyl group, the 
GDP-bound Rab remains in the cytosol and is inactive (Fig. 1.1A). Removal of GDI 
exposes the prenyl group, allowing the Rab to be inserted into the target membrane 
(Fig. 1.1B). A Rab guanine nucleotide exchange factor (GEF) exchanges GDP for 
GTP, resulting in an active, membrane bound Rab which, in its active conformation, 
can then recruit its effector proteins (Fig. 1.1C). A GTPase-activating protein (GAP) 
activates the intrinsic GTPase activity of the Rab, which hydrolyses GTP to GDP, 
enabling the Rab to be extracted from the membrane by GDI (Fig. 1.1D) (Nottingham 





Fig. 1.1. The Rab guanine nucleotide cycle  
Rab proteins cycle between their GDP and GTP bound state, and move between the 
cytosol and their target membrane. Refer to text for description. GEF: guanosine 
nucleotide exchange factor; GAP: GTPase activating protein; GDI: GDP dissociation 




The eukaryotic cell is highly compartmentalised, and specific transport 
processes occur between the different compartments (Deneka et al., 2003). In the 
exocytic pathway, anterograde transport of endoplasmic reticulum (ER) targeted 
nascent protein occurs as they are transported from the ER to the Golgi apparatus 
(GA). Extracellular or membrane proteins exit the GA and are then sorted at the trans-
Golgi network (TGN) into secretory vesicles (SV), while intracellular proteins are 
sorted to their various organelles. In the endocytic pathway, retrograde transport 
occurs. Endocytosis is the process by which the plasma membrane of a cell 
invaginates, enabling it to internalise extracellular fluids, proteins and other signalling 
molecules into vesicles which fuse to form early endosomes. Sorting at the endosomal 
network takes place, and proteins such as signalling molecules may be targeted for 









recycled back to the cell surface via recycling endosomes (RE). Traffic also occurs 
between the Golgi and the various membranous compartments such as the ER and the 
endosomal network, and is a means by which proteins with functions in the 
compartments themselves are targeted and recycled (Fig. 1.2).  
 
 
Fig. 1.2. Schematic diagram of intracellular membrane trafficking pathways  
The endocytic pathway involves retrograde transport (red arrows) and the 
exocytic/biosynthetic pathway involves anterograde transport (green arrows). Cargo 
at the early endosome can also be recycled to the plasma membrane or returned to the 
TGN (black arrows). Proteins localised to various membranous compartments are 
themselves trafficked and recycled to and from the Golgi (dotted arrows). Refer to 
text for more details. ER: Endoplasmic reticulum; GA: Golgi apparatus; TGN: trans-
Golgi network; SV: Secretory vesicle; EV: Endocytic vesicle; EE: Early endosome; 
RE: recycling endosome; LE: late endosome; L/V lysosome/vacuole.  
 
Rabs confer specificity to particular vesicular transport steps by virtue of their 
large repertoire of specific interacting proteins as well as via their specific subcellular 
location along the vesicular transport pathways (Segev, 2011; Grosshans et al., 2006). 




1.1.1 Rab-interacting proteins and how they aid in achieving specificity in Rab 
function 
As discussed above, Rabs interact with a variety of regulatory proteins which 
serve to activate or deactivate them, as well as effector proteins that act downstream. 
Specificity of Rab function is thus conferred by these proteins, which are interacting 
partners to specific Rabs or subfamilies of Rabs.  
 
a) Rab guanine nucleotide exchange factors (GEFs)  
GDP dissociates from Rab proteins at a very low rate, and GEFs serve to catalyse 
the exchange of GDP for GTP on the Rab protein by altering the conformation of the 
nucleotide binding site, promoting GDP dissociation. This then enables GTP, which 
exists in much higher concentrations in the cell, to associate with the Rab. GEFs thus 
aid in the activation of the Rab. In general, they have a higher affinity for the GDP-
bound form of the Rab, and therefore dissociate from the Rab once it is GTP-bound 
and activated. One Rab can have many activating GEFs. For example, Rab5’s GDP-
GTP exchange could be aided by GAPex5 (Hunker et al., 2006) (also known as RME-6 
in C. elegans (Sato et al., 2005)), Ras and Rab interactor 1 (RIN1) (Tall et al., 2001), 
Rabex5 (Horiuchi et al., 1997), and Alsin  (Topp et al., 2004).  
That these GEFs serve different cellular functions is hinted at by the fact that they 
have other functional and/or regulatory domains other than the GEF domain, and also 
exhibit different subcellular localisation within the cell (van der Bliek, 2005). To 
elaborate further, various protein domains have been delineated to be associated with 
Rab GEF function. Amongst them is the Vps9 domain, which serves as a GEF for 
members of the Rab5 subfamily, and is found in 18 mammalian proteins (Delprato et 




of proteins, which besides the Vps9 domain also contains a Ras association (RA) 
domain that enables Ras-dependent allosteric regulation of the proteins’ GEF activity 
(Tall et al., 2001; Bliss et al., 2006; Yoshikawa et al., 2008). This suggests that regulatory 
mechanisms of GEFs exert spatial and temporal control of Rab activity.  
The Differentially Expressed in Normal and Neoplastic cells (DENN) domain is 
another putative GEF domain. The DENN domain of the connecdenn family of 
proteins acts as a GEF for Rab35 (Allaire et al., 2010). Several different functions have 
been attributed to Rab35, including fast recycling on early endosomes, and 
modulation of actin dynamics via the actin bundling protein fascin, a Rab35 effector 
(Marat et al., 2012; Chua and Tang, 2011). It is proposed that different DENN domain 
proteins act as GEFs for Rab35 in specific contexts to control the diverse functions of 
the Rab (Marat and McPherson, 2010). Again, this suggests that the different GEFs also 
aid in determining the specificity of Rab function.  
 
b) Rab GTPase activating proteins (GAPs)  
GAPs terminate the activity of Rab proteins by stimulating the intrinsically low 
Rab GTPase activity to hydrolyse bound GTP. GAPs bind to Rabs and induce a 
conformational change in the Rab that exposes the GTP to facilitate nucleophilic 
attack by water, which hydrolyses the GTP by breaking the phosphate bond. To date, 
all identified Rab GAPs contain a Tre2/Bub2/Cdc16 (TBC) domain (Pan et al., 2006; 
Fukuda, 2011). Over 50 TBC domain-containing proteins have been found in humans, 
but their functions are poorly characterised (Gabernet-Castello et al., 2013). It is 
believed that a conserved arginine finger within the domain interfaces with the Rab 




2011). GAPs also aid in the specificity and function of Rabs by determining their 
subcellular localisation, discussed later below.  
 
c) Rab Effectors  
Effector proteins refer generally to any protein that interacts with the activated, 
GTP-bound Rab. Rabs regulate vesicular transport in the cell by engaging various 
effector proteins, such as motor proteins, tethering factors, and fusion components 
such as SNAREs (soluble N-ethylmaleimide sensitive factor (NSF) attachment 
protein (SNAP) receptor) (Markgraf et al., 2007; Seabra and Coudrier, 2004; Li, 2001; 
Simonsen, 1999).  
Rabs aid membrane vesicle motility by recruiting motor proteins. Rab7 mediates 
fusion between late endosomes and lysosomes. One of its effectors is the intermediate 
filament associated protein, Rab-interacting lysosomal protein (RILP), which recruits 
dynein-dynactin motor complexes to the late endosome and lysosomes and enables 
the transport towards the minus-end of microtubules (Jordens et al., 2001). 
Many Rabs have also been shown to recruit tethering factors, which facilitate the 
docking and subsequent fusion of vesicles. For example, Rab1 has been shown to 
bind p115, which aids in the fusion of ER-emerging COPII vesicles with the Golgi 
membrane (Beard et al., 2005; Grabski et al., 2012). Rab5 has been shown to bind early 
endosome antigen 1 (EEA1), a tethering factor which mediates homo- and hetero-
typic fusion between early endosomes (Dumas et al., 2001; Simonsen, 1999).  
Rabs also engage SNAREs, which are responsible for mediating vesicular fusion 
(Stenmark, 2009; Segev, 2011). Rab5 was found to assemble into a large oligomeric 
complex which includes the Rab5 interacting proteins EEA1, Rabaptin5, and Rabex5, 




Syntaxin13 interacts with this complex (McBride et al., 1999). Using reconstituted 
proteoliposomes, it was later confirmed that Rab5 helps to stabilise the presence of 
the syntaxins on the membranes to aid fusion (Ohya et al., 2009).  
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Table. 1.1. Rab effector proteins  
Examples of types of effector proteins and their Rabs. GA – Golgi apparatus, ER - 
endoplasmic reticulum, EE – early endosome, PM – plasma membrane. See text for 







1.1.2 Localisation of Rab proteins to target membranes 
Another aspect of Rab specificity lies in their specific subcellular localisation 
within the cell. Rabs function while associated with their respective target membranes 
(Fig. 1.3). How Rabs are targeted specifically to a particular membrane is therefore of 
great interest. Conceivably, this is partly dependent on the Rab-interacting proteins, 
but also on structural domains within the Rab proteins. Newly synthesised Rabs are 
soluble cytosolic proteins that are post-translationally modified by prenylation 
(typically the addition of two geranyl groups) to its C-terminal cysteine residues 
linked by thioether bonds. This is mediated by Rab escort proteins (REP), which 
chaperone the newly synthesised Rabs to Rab geranylgeranyl transferases (RGGTase) 
(Pereira-Leal et al., 2001). After prenylation, Rabs can be lipid-anchored into their 
target membranes, where they undergo GEF-mediated GDP-GTP exchange and 
engagement of effector proteins. GAPs enhance the intrinsic GTPase activity of the 
Rabs, resulting in inactivation (Nottingham and Pfeffer, 2009). GDP-bound Rabs can 
then be extracted from the membrane by GDP dissociation inhibitors (GDI), which 
have higher affinity for the GDP-bound form of prenylated Rab (Ullrich et al., 1993; 
Ullrich et al., 1994; Soldati et al., 1994). Through a variety of different speculative 
mechanisms, Rabs can then be dissociated from GDI and reinserted into the 





Fig. 1.3. Schematic diagram illustrating subcellular localisation of various Rab 
proteins  
Examples of different Rabs and their unique subcellular localisation. ER: 
Endoplasmic reticulum; GA: Golgi apparatus; TGN: trans-Golgi network; EE: Early 
endosome; RE: recycling endosome; LE: late endosome; L/V lysosome/vacuole. 
 
 
Different Rabs largely occupy different subcellular compartments, and even 
within the same membrane compartment, different Rabs may occupy different 
membrane microdomains. For example, Rab5 and Rab4 both exist on endosomes but 
occupy different microdomains and have different functions. Rab5 typically mediates 
homo- and heterotypic endosomal fusion while Rab4 mediates fast recycling directly 
to the plasma membrane (De Renzis et al., 2002). Rab7 and Rab9 also occupy separate 
microdomains on late endosomes, and also mediate separate processes. Mannose 6-
phosphate receptors (M6PR) carry newly synthesised lysosomal enzymes from the 
TGN to late endosomes/lysosomes, and is itself recycled to the Golgi, a step which is 




microdomains. In contrast, Rab7 has been shown to play a role in the degradation of 
cargo from the plasma membrane that enters the endocytic-degradative pathway (Feng 
et al., 1995; Vanlandingham and Ceresa, 2009).  
Many different mechanisms, based both on Rabs’ primary structure and Rab 
interacting proteins, have been put forth to postulate how Rabs are first targeted to 
their specific membranes / organelles and then held there in microdomains by 
interactions with a variety of proteins. The following discusses some of these 
mechanisms: 
 
a) Rab hypervariable domain 
The Rab hypervariable (HV) domain refers to the sequence variability of 
approximately 35-40 amino acids that exists between the last α-helix and the C-
terminal prenylation region. It is especially important for the hydrophobic interactions 
with GDI (Pfeffer, 2005), which binds at the top to switch regions and at the bottom to 
the prenylation group (Pfeffer and Aivazian, 2004). Evidence for the importance of the 
HV domain in determining Rab specificity has been varied. For example, in terms of 
engaging interacting proteins, the HV domain of Rab5 has been shown to be 
dispensable for EEA1 interaction (Merithew et al., 2003; Mishra et al., 2010). Moreover, 
as evidenced by members of the Rab5 subfamily (described in more detail in Section 
1.2), Rabs with different HV domains can still have the same effectors and, to some 
extent, similar subcellular localisations. With regards to whether the HV domain is 
important to Rab subcellular location, in early studies using Rab5 chimeric proteins 
consisting of the Rab5 backbone and the Rab7 HV domain, no mistargeting of the 
Rab5 protein was observed. However, a deletion of the HV domain did render the 




suggesting that the HV region may still be important for correct folding, or post-
translational modifications before a Rab can become membrane-associated. Hence, 
while the HV domain may not be necessary for specific membrane targeting per se, it 
is important for membrane association. More recent studies using chimeric proteins 
have also suggested that the HV domain was dispensable for correct membrane 
localisation (Ali et al., 2004). However, in one study, it was shown that the Rab9 HV 
domain was necessary and sufficient for binding to its effector, Tail-interacting 
protein of 47kDa (TIP47) (as long as a Rab backbone is also present). Chimeras 
consisting of Rab5 or Rab1 backbone with Rab9 HV domain were all able to interact 
with TIP47 (Aivazian et al., 2006). As discussed below, TIP47 was subsequently found 
to be the interacting partner responsible for correct membrane targeting of Rab9. It is 
pertinent to mention, however, that the converse need not be true – the Rab5 HV 
domain appeared to play little importance in the interaction with its effector EEA1, 
nor its early endosome localisation. Thus, it would seem that the HV region varies in 
importance for specificity of Rab membrane association, depending on the particular 
Rab protein.  
 
b) Rab prenylation and prenylation machinery: 
Dual prenylation of Rabs has also been shown to be important for specific 
targeting, as Rabs which have been altered to have only a single prenylatable C-
terminal cysteine were mistargeted to the ER (Gomes et al., 2003; Calero et al., 2003). 
The exact reasons for this is unknown, but has been postulated to occur due to the 
specific requirements for REPs and RGGTs, which may associate with other factors 
important for correct membrane targeting. It is postulated that REPs may be 




2004), but no direct evidence for this currently exists. Moreover, because only a few 
REPs have been identified (there are only two isoforms in mammalian cells) (Goody et 
al., 2005) and are believed to serve a wide variety of Rabs, it would seem unlikely that 
specificity is conferred solely by the REPs. 
 
c) GDP dissociation inhibitors (GDI) and GDI displacement factors (GDF):  
Conserved residues on the GDI as well as those on the switch regions of Rabs 
enable a few GDIs to recognise an extensive range of Rab proteins. As such, it is 
unlikely that a few GDIs could be responsible for the wide variety of locations to 
which Rabs are targeted. However, there is some evidence that the GDI is important 
to membrane association. Purified Rab5-GDI complexes added to Streptolysin O-
permeabilised Madin-Darby canine kidney cells enabled Rab5 to be inserted into 
membranes, whereas non GDI-bound Rab5 aggregated (Ullrich et al., 1994). Similarly, 
Rab9-GDI complexes could load Rab9 onto membranes isolated from the late 
endosome but not the ER, suggesting that the Rab-GDI complexes may carry some 
information on subcellular membrane specificity (Soldati et al., 1994).  
There is also evidence for the existence of a GDI displacement factor (GDF), 
which would help to dissociate the GDP-bound Rab from the GDI at the target 
membrane. A protein factor purified from endosomes was shown to catalyse the 
release of GDP from the GDI-Rab9 complex in reconstituted liposomes, enabling 
GTP binding. As it did not enhance the intrinsic nucleotide exchange of prenylated 
Rabs, it was therefore not a GEF, and was instead termed a GDF. Interestingly, it also 
catalysed the GDP release of other endosomal Rabs such as Rab5 and 7, suggesting 
perhaps that the localisation of the GDF defines, in part, its specificity of action, and 




Svejstrup et al., 1997). Another protein, Yip3, was also identified as a potential GDF. 
Yip3 catalysed the release of GDP from the GDI-Rab9 complex, enabling GTP 
binding and the subsequent insertion of Rab9 into the reconstituted liposomal 
membrane. Yip3 also did not enhance the intrinsic exchange of prenylated Rabs 
(Sivars et al., 2003). Evidence for other GDFs has been scant, however, and a 
consistent role in specific membrane targeting has also not been shown.  
 
d) Guanine nucleotide exchange factors (GEFs):  
Guanine nucleotide exchange may be another way by which GDP-bound Rab-
GDI complexes are targeted to membranes. The subsequent GDP-GTP exchange 
catalysed by the GEF causes dissociation from GDI, as GDIs have reduced affinities 
for GTP-bound Rabs. Incidentally, it is contended that this would replace the need for 
GDF as an intermediate (Wu et al., 2010). Recent studies have supported the idea that 
GEFs are integral to the correct targeting of Rabs to membranes. Artificial targeting 
of the Rab5 GEF Rabex5 to the mitochondrial membrane resulted in a concomitant 
targeting of Rab5 from the endosome to the mitochondria. Reduction of the GEF 
activity of Rabex5 by targeted mutations to the VPS9 domain abolished this effect 
(Blumer et al., 2013). In another study, when Rab3GEP, the non-redundant GEF for 
Rab27a, was silenced, Rab27a was no longer targeted to melanosomes, but was 
instead mislocalised to perinuclear membranes. Rab3GEP is necessary but not 
sufficient for correct targeting, however, as other Rab27a mutants have been 
identified which retained the ability to bind Rab3GEP, but are still not correctly 
targeted (Tarafder et al., 2011).  
If GEFs are indeed responsible for Rabs’ membrane targeting, it then begs the 




targeted to the specific membrane. One possibility is that these are membrane 
localised by a preceding Rab cascade. For example, the GEF for the late endosome-
localised Rab7, the Hsp70-Hsp90 Organising Protein System (HOPS) complex, is 
initially localised to endosomal membranes because it interacts as an effector protein 
with Rab5, which precedes Rab7 on early endosomes (Rink et al., 2005). Another 
possibility is that the GEFs interact with other machineries located on the targeted 
membrane. For example, the Rab35 GEF connecdenn1 is recruited to endosomes that 
were formed from clathrin-mediated endocytosis via its interaction with AP2, the 
clathrin adaptor protein (Marat and McPherson, 2010).  A third possibility is that the 
GEFs are themselves stabilised by a positive feedback loop. A typical example is that 
of the Rabex5-Rab5-Rabaptin5 complex, in which the Rab5 effector, Rabaptin5, 
stabilises the presence of the Rab5 GEF Rabex5 on endosomal membranes, enabling a 
synergistic association in a Rab5 microdomain on the endosome (Lippé et al., 2001). 
 
e) Effectors: 
The requirement for effector proteins in determining Rab subcellular localisation 
also appears to vary between Rabs. Rab27a mutants that are deficient in effector 
binding were still correctly localised to the melanosomes (Tarafder et al., 2011). The 
situation for Rab9, however, differs. Rab9, found on late endosomes, is required for 
the retrograde transport of mannose 6-phosphate receptor (M6PR) from the late 
endosome to the trans-Golgi network. TIP47, a Rab9 effector, has a high affinity for 
M6PR, and thus serves as a bridge between the Rab and its cargo. A chimera 
consisting of the Rab5 backbone and the Rab9 HV domain was found to bind both 
Rab5 and Rab9 effectors, and was found on the early endosome (the target membrane 




endosome, highlighting the importance of the Rab9 effector interaction in determining 
its localisation, perhaps by creating a microdomain that enhances interactions through 
positive feedback (Aivazian et al., 2006). It is however of note that another Rab9 
effector, p40, did not present the same effect. Also, depletion of TIP47 did not 
mislocalise Rab9. Together, the evidence suggests that there may be certain specific 
effectors that are important for localisation, but also that there may be redundancy in 
the system. 
 
f) GTPase activating proteins (GAPs): 
Although GAPs are, in a sense, the last in a series of interacting proteins that bind 
to a Rab in a Rab activation cycle, they also appear to be important in maintaining 
specific Rab domains on a membrane (Nottingham and Pfeffer, 2009). For example, 
Gyp1, an effector for yeast Rab Ypt32, acts as the GAP for the yeast Rab Ypt1. Both 
Ypt1 and Ypt32 are found on the Golgi membranes, with Ypt1 facilitating intra-Golgi 
transport and Ypt32 facilitating Golgi exit. As such, via Gyp1, Ypt32 is able to 
maintain a Ypt1-free zone, enabling each Rab to maintain a separate domain on the 
Golgi (Rivera-Molina and Novick, 2009).  
 
1.1.3 Rab cascades and crosstalk between Rabs and their interacting proteins 
A concept in membrane trafficking that is rapidly gaining experimental 
support and popularity is that of Rab cascades, referring to the progressive 
recruitment of Rab and/or Rab interacting proteins, such that a particular membrane 
compartment gradually takes on a different Rab protein from the initial Rab, and thus 




One classic example, already briefly described above, is that of the 
progression of Rab5 early endosomal compartments to Rab7 late endosomal 
compartments, thus facilitating the maturation from early to late endosome (Rink et al., 
2005). Using a quantitative live cell imaging approach, the authors identified Rab5 
early endosome compartments that gradually lost Rab5 and acquired Rab7. This 
maturation into late endosomes was mediated by the Class C VPS/HOPS complex, 
which is an effector for Rab5-GTP, and a GEF for Rab7 (Rink et al., 2005). A further 
layer of complexity was found in the C. elegans SAND1/Mon1, which was shown to 
displace Rabex5. This would ensure that the positive feedback associated with 
Rabex5-Rabaptin5 is terminated, thus enabling the endosome to mature to a Rab7-
dontaining one. As SAND1/Mon1 recognises phosphotidyl inositol 3-phosphate 
(PI3P), it was postulated that SAND1/Mon1 binds only the more mature endosomes, 
which would have accumulated a large amount of PI3P via the action of 
phosphotidylinositol-3-kinase (PI3K), a Rab5 effector. In this way, Rabex5 is only 
displaced when the early endosome is ready to mature to a late endosome. 
SAND1/Mon1 also binds to Class C VPS/HOPS complex, enabling the recruitment of 
Rab7 (Poteryaev et al., 2010) .  
Another example of a GEF being an effector of the preceding Rab in a cascade 
is the Rab22-Rabex5-Rab5 cascade (Zhu et al., 2009). Rabex5 consists of a GEF 
domain that contains a helical bundle and a VPS9 domain. Downstream of the GEF 
domain is the Rabaptin5 binding domain. Rabex5 also has an early endosomal 
targeting (EET) domain. Using a series of GST- affinity pulldown assays, Rabex5 was 
found to be an effector for Rab22, while serving as a GEF for Rab5. Rabex5 is 
recruited to Rab22 GTP-containing early endosomes via its EET domain. Rabex5 can 




between various Rab-mediated endocytic pathways, it was found that overexpression 
of Rabex5 enhanced Rab5-mediated endosomal fusion but inhibited Rab22-mediated 
endosomal fusion, presumably because it competed with EEA1, the other Rab22 
effector which is responsible for mediating fusion.  
Sometimes, the same GEF can serve two consecutive Rabs, by recruiting a 
different subset of subunit proteins. The TRAnsport Protein Particle complex (TRAPP) 
in yeast is a multisubunit tethering complex on the Golgi that acts as a GEF for two 
different Rabs that function in two separate Golgi compartments. Ypt1 mediates ER-
Golgi and intra-Golgi transport, while Ypt32 mediates exit from the Golgi. To ensure 
specificity of action, the TRAPP complex engages different subunits for the different 
steps. TRAPP I consists of 7 subunits while TRAPP II acquires an additional 3 
subunits, thus switching the GEF specificity (Morozova et al., 2006).  
Similarly, a divalent effector can bind to two consecutive Rabs. Rabenoysn5 
was initially identified as a Rab5 effector, with a FYVE zinc finger domain (named 
after the cysteine rich Fab1, YOTB, Vac1, and EEA1 proteins). It was later shown to 
also bind Rab4-GTP in the same complex. In this way, Rab5 early endosomes can be 
channelled into the recycling pathway via recruitment of Rab4. Overexpression of 
Rabenosyn5 was shown to stimulate the fast recycling of the transferrin receptor (De 
Renzis et al., 2002).  
These examples of Rab cascades highlight the complexity of Rab interactions 






1.2 Overview of the Rab5 subfamily  
Rabs have highly conserved domain motifs (Deneka et al., 2003). As with all 
small GTPases, Rabs contain two switch regions that change conformation upon GTP 
binding, enabling the engagement of various effector proteins. The five Rab family 
motifs are unique to the Rab family amongst the other small GTPases. Four regions, 
termed the subfamily regions, also have high homology within Rab subfamilies. The 
hypervariable region has the least sequence conservation (Fig. 1.4). These domain 
motifs are a means by which Rabs can be classified.  
 
Fig. 1.4. Structural domains of Rab proteins 
Domain motifs of Rabs which are highly conserved amongst the small GTPases. See 
text for more details. F: Family domain; SF: Subfamily domain; SW: Switch region; 
GG: prenylation domain; HV: Hypervariable domain.  
 
The Rab5 subfamily of Rab proteins includes Rab5, Rab21, Rab22 and Rab31 
(Pereira-Leal and Seabra, 2001). Members of this subfamily have been implicated in a 
variety of endocytosis-related trafficking steps, including that of cell surface receptors 
(Bucci et al., 1992; Simpson et al., 2004; Kauppi et al., 2002).  
 
1.2.1 The endocytic system intersects with cellular signalling  
As illustrated above, Rabs play important roles in membrane trafficking 
pathways within the cell, and the Rab5 subfamily is particularly important in the 
endocytic trafficking pathway. The endocytic system, in turn, is important in the 
control of cellular signalling pathways that are triggered by ligand binding to 




2001). Once ligand-bound, receptors can be endocytosed through the interaction 
between the tyrosine or di-leucine based motifs in their cytoplasmic tails with clathrin 
adaptor protein complex AP2 (Sorkin and von Zastrow, 2009). Ubiquitin also serves as a 
signal for receptor-mediated endocytosis. Ubiquitinated epidermal growth factor 
receptor (EGFR), for example, is recruited to clathrin coated pits via the ubiquitin-
binding domains on Epsin, which itself mediates the interaction with clathrin (Sen et 
al., 2012). Ligand-receptor complexes that are internalised can be recycled or degraded. 
For example, the transferrin receptor or low-density lipoprotein receptor is recycled 
back to the cell surface, while receptors like EGFR or ligands like low-density 
lipoprotein are degraded. In this way, duration and strength of signalling is controlled. 
As such, Rab proteins such as those in the Rab5 subfamily can be expected to be 
important in the regulation of duration and strength of signalling.  
Signalling activities can still persist while in endosomes. EGFR, for example, 
remains ligand-bound and phosphorylated while in endosomes. In an attempt to study 
the effect of endosomal signalling without input from plasma membrane signalling, 
the authors first treated cells with EGF in the presence of AG1478 and monensin, a 
tyrosine kinase inhibitor and inhibitor of receptor recycling respectively, which 
resulted in the internalisation of non-active ligand-bound EGFR. The inhibitors were 
then removed to allow signalling from endosomes to occur. The authors found that 
mitogen activated protein kinase (MAPK) continued to be phosphorylated by this 
process, but not phospholipase C (PLC) γ, which suggests that endosomal signalling 
differs somewhat from signalling at the plasma membrane, in which both MAPK and 
PLCγ become phosphorylated (Wang et al., 2002). As another example of signalling 
effects that occur when receptors are endocytosed, an endosomal pool containing 




domain, pleckstrin homology (PH) domain, leucine zipper-containing protein 1) is 
also important for signalling that mediates cell proliferation. To elaborate, upon 
ligand activation of EGFR, PI3P accumulates on the early endosome. EEA1, which 
has PI3P-binding domains, is recruited to the early endosome and competes with 
APPL1 for Rab5-binding. As more EEA1 is recruited, APPL1 is eventually displaced 
from Rab5 (Zoncu et al., 2009) . Dissociated APPL1 translocates to the nucleus where 
associates with the nucleosomal remodelling and deacetylase complex  
(NuRD)/MeCP to mediate cell proliferation (Miaczynska et al., 2004). This is thus 
another example of how Rabs intersect with cellular signalling pathways.  
 While endocytosis mediates signalling, signalling can also mediate various 
aspects of endocytosis. For example, activation of EGFR leads to an increase in 
clathrin coated pit formation, by phosphorylating the clathrin heavy chain in a region 
that mediates the formation of the clathrin triskelion (Wilde et al., 1999). Also, tyrosine 
kinase activity of EGFR is believed to be important for Rab5 activation, through the 
recruitment of the RIN1, the Rab5 GEF, to the EGFR-bound Growth factor receptor-
bound protein 2 (Grb2) and its downstream substrate p21Ras, which relieves the 
autoinhibition on RIN1 (Jozic et al., 2012).  
 
1.2.2 Rab5 subfamily members and the EGFR trafficking pathway 
Cell surface receptors are constantly endocytosed, both constitutively and 
when bound by its ligands. EGFR, for example, exists at steady state on the cell 
surface as a monomer. Upon binding of EGF or other ligands, the receptor dimerises 
and autophosphorylates, initiating a resultant signalling cascade by serving as a 
docking site for Src-homology 2 (SH2) or phosphotyrosineB (PTB) domain 




and Epsin8. In the canonical pathway, Grb2 recruits Son of Sevenless, a GEF for 
p21Ras, via its Src-homology 3 (SH3) domains interacting with proline-rich 
sequences. Activated p21Ras facilitates the membrane recruitment and activation of 
Raf kinase, which triggers the Raf/MEK/MAPK pathway of cell signalling (Martinu et 
al., 2002). At the same time, ligand-bound EGFR is internalised from the plasma 
membrane and trafficked to early and late endosomes and eventually degraded in 
lysosomes, which results in a termination of its signalling (Sorkin and Goh, 2009; 
Ceresa, 2006). Alternatively, the receptor may be recycled to the cell surface (Masui et 
al., 1993). Different EGFR ligands trigger different endocytic sorting of the receptor. 
For example, EGF triggers both recycling and degradative pathways, whereas the 
transforming growth factor TGFα largely triggers recycling (Roepstorff et al., 2009). 
Many Rabs, including those of the Rab5 subfamily, have been implicated to varying 
extents in various trafficking steps of the EGFR internalisation pathway. For example, 
Rab5 (Huang et al., 2004) and Rab 21 (Simpson et al., 2004) have been shown to enhance 
the movement of EGFR from the cell surface into early endosomes, while Rab22 (the 
closest paralogue to Rab5 (Mishra et al., 2010)), as well as Rab21, have been 
implicated in the later trafficking steps, with a general role in recycling or terminating 
the EGFR signalling in late endosomes / lysosomes (Kauppi et al., 2002). In some 
studies, loss of Rab5 activity (either by siRNA or use of dominant negative Rab5 
S34N) has also been shown to inhibit the exit of ligand-bound EGFR from the early 
endosome (Chen et al., 2009; Dinneen and Ceresa, 2004). The following section discusses 








Rab5 has 3 distinct isoforms (Rab5a, b and c) which share 80% homology. All 
serve to mediate early endosomal dynamics, but slight differences in tissue 
distribution, phosphorylation profiles etc. have been observed (Chiariello et al., 1999).  
Rab5a has been shown to be the main isoform required for EGFR trafficking. 
Silencing of Rab5a reduced the rate of degradation of EGFR in HeLa cells, while 
overexpression accelerated it (Chen et al., 2009). Only when all 3 isoforms of Rab5 
were depleted was EGFR internalisation delayed (Huang et al., 2004; Chen et al., 2009), 
which led to the conclusion that Rab5 was more important for endosomal trafficking 
of EGFR than the initial internalisation of EGFR from the plasma membrane. EEA1, 
an effector of Rab5, was not displaced from early endosomal structures when Rab5 
was silenced, suggesting that Rab5 alone was not essential for the localisation of 
EEA1 on early endosomes, and that the perturbation of EGFR trafficking seen was 
not due to a general disruption of endosomal dynamics (Chen et al., 2009). Silencing of 
Rab5 delayed the exit of EGFR from early endosomes. Of note is that it only delayed 
but did not completely block this exit, suggesting that the cell can still overcome the 
blockage, perhaps by compensatory mechanisms. RIN1 was the main GEF 
responsible for the observed Rab5 effect on EGFR trafficking (Chen et al., 2009). In 
another study, the dominant negative Rab5S34N did not perturb internalisation but 
affected the rate of degradation (Dinneen and Ceresa, 2004). There was now a 
delocalisation between Rab5 S34N positive endosomes and those containing EGFR, 
although internalisation of EGFR into endosomal pools still occurred (Dinneen and 
Ceresa, 2004). Again, this suggested that Rab5 played a more important role in EGFR 




However, in other studies, Rab5 was also shown to have a role in EGFR 
internalisation from the cell surface. It was first found that in NR6 cells, dominant 
negative Rab5 S34N inhibited internalisation of ligand-bound EGFR (Barbieri et al., 
2000). This was corroborated in HeLa cells, and injection of antibodies targeted to 
Rabaptin5, the Rab5 effector, also had the same effect (Chen and Wang, 2001). Also, 
the Rab5 GAP RN-tre was found to bind Grb2, and overexpression of RN-tre was 
found to inhibit internalisation of ligand-bound EGFR (Martinu et al., 2002). At the 
same time, activated Ras binds RIN1, releasing the effect of autoinhibition and 
enabling RIN1 to catalyse the GDP-GTP exchange on Rab5, enhancing receptor-
mediated endocytosis (Tall et al., 2001). In contrast to the studies described in the 
previous paragraph, these studies suggest that Rab5 might also have a role in 
endocytosis of EGFR from the plasma membrane. The differences in observations 
might be due to the use of different cell types, which may differ in the localisation of 
exogenously expressed Rab5, and serves to highlight the variation in roles of Rab5 in 
EGFR trafficking. Incidentally, the studies by Martinu et al. (2002) and Tall et al. 
(2001) also provide evidence that receptors can recruit both GEFs and GAPs for a 
given GTPase. It is likely that the GEF and GAP work in concert to regulate the 
intricacies of EGFR internalisation and trafficking.  
 
b) Rab22 
Rab22 is localised on early endosomes and shares 52% sequence identity with 
Rab5. Silencing of Rab22 blocks the recycling of endocytosed cargoes like the 
transferrin receptor and major histocompatibility complex (MHC) I (Zhu et al., 2009). 
Rab22 is found on endosomes and interacts with EEA1 at its N-terminal region only 




active mutant Rab22 Q64L does not perturb internalisation of ligand-bound EGFR but 
does perturb its degradation. In fact, overexpression of wild-type, activating or 
inactivating mutants of Rab22 all decreased the degradation of EGF (Ceresa, 2006). 
This suggests that Rab22 needs to be recycled, perhaps because both the active and 
inactive form of Rab22 interact with specific proteins required for EGFR trafficking. 
A redistribution of various endocytic markers was also observed, leading the authors 
to suggest that the effect of Rab22 may be due, in part, to a general perturbation of the 
endocytic pathway. For example, it is also postulated that Rab22 facilitates interaction 
between TGN-derived membranes and the early endosome (Kauppi et al., 2002).  
 
c) Rab21 
Rab21 is predominantly localised to early endosomes (Egami and Araki, 2008). 
Cells overexpressing a Rab21 dominant negative mutant, Rab21 T33N, had defects in 
both internalisation of ligand-bound EGFR from the cell surface and subsequent 
trafficking from early to late endosomes (Simpson et al., 2004). Rab21 also plays a role 
in the internalisation of integrins from the cell surface. Rab21 binds directly to 
integrins via the α-tail, albeit in a nucleotide independent manner. p120RasGAP 
(which is not a GAP for Rab21) competes with Rab21 for integrin binding, and in this 
way regulates the presence of integrins in Rab21 endosomal compartments (Mai et al., 
2011). More recently, Rab21 has also been shown to bind EGFR and overexpression 
of Rab21 enhances both unliganded and liganded EGFR internalisation from the cell 
surface, as analysed by confocal microscopic images, as well as degradation of 
unliganded EGFR, hence attenuating MAPK signalling (Yang et al., 2012). This is in 




stimulation has been shown to be important for activation of Rab5, by relieving the 
inhibition on RIN1 (Barbieri et al., 2000) 
 
1.2.3 Other Rabs implicated in the EGFR trafficking pathway 
Although not part of the Rab5 subfamily, it is worth mentioning some other 
Rabs that have also been implicated in EGFR trafficking (Ceresa, 2006). Rab4 and 
Rab11 have both been implicated in the endosomal recycling pathway. Expression of 
Rab4 dominant negative mutant Rab4 S22N resulted in a decrease in both recycling 
and degradation of EGFR, leading the authors to postulate that Rab4 is important for 
sorting in the early endosomal compartment (McCaffrey et al., 2001). Meanwhile, the 
Rab11 family interacting protein 2 (Rab11FIP2) has been shown to affect both 
receptor internalisation as well as recycling, leading the authors to suggest that the 
protein may be important for coupling internalisation to recycling of the EGFR (Cullis 
et al., 2002). Rab7 has been linked to the maturation of EGFR-containing late 
endosomes to lysosomes (Vanlandingham and Ceresa, 2009), as silencing of Rab7 
blocks the exit of EGFR from the late endosome and reduces the rate of EGFR 
degradation (Ceresa and Bahr, 2006).  
 
1.2.4 Introduction to Rab31  
Rab31 was first cloned from human melanocyte cDNA and has been classified 
under the Rab5-related subfamily, based on sequence homology (Chen et al., 1996). 
Colleagues in the laboratory have previously reported that Rab31 is localised to the 
perinuclear region of the cell, colocalising with trans-Golgi network (TGN) markers 




GAPex5 was first confirmed as a Rab31 GEF in studies looking at the insulin 
regulated trafficking of the glucose transporter Glut4. Although it can also serve as a 
GEF for Rab5, it has been shown to have a higher affinity for Rab31 (Lodhi et al., 
2007). It contains an N-terminal Ras-GAP domain, a central PXXP sequence similar 
to other SH3 domain-binding sequences, and also a C-terminal VPS9 GEF domain for 
Rabs (Fig. 1.5 upper panel). The SH3 domain of Cdc42-interacting protein 4 (CIP4) 
was found to bind the PXXP sequence of GAPex5. The authors postulated that Glut4 
in intracellular vesicles is normally held there in a futile cycle of fusion between 
vesicles that is mediated by active Rab31. When adipocytes are stimulated with 
insulin, CIP4 has been shown to translocate to the plasma membrane; GAPex5 thus 
translocates as well. As a result, the GAPex5 activation of Rab31 within the cell is 
lost. When Rab31 is no longer active, Glut4 is then freed from its futile cycle of 
fusion and released at the plasma membrane in response to insulin. In HeLa cells, 
GAPex5 has also been identified to bind to EGFR through Casitas B lineage 
lymphoma protein (Cbl), an E3 ubiquitin ligase, upon receptor dimerisation (Su et al., 
2007). Cbl binds to phosphotyrosine motifs on ligand-bound EGFR and is responsible 
for the ubiquitination of EGFR, which serves as both an internalisation and 
degradation signal. GAPex5 interacts with Cbl via its Ras-GAP domain. RIN3 was 
identified more recently as another Rab31 GEF. It has an SH2 and proline-rich (PR) 
domain in the N-terminal region, as well as RIN-family homology (RH), VPS9, and 
Ras-association (RA) domains in the C-terminal region (Fig. 1.5 lower panel). It has 
higher GEF activity for Rab31 than for the other Rab5 subfamily proteins such as 





Fig. 1.5. Domains of Rab31 GEFs GAPex5 and RIN3  
GAPex5 and RIN3 both contain the Vps9 GEF domain. See text for more details. PR: 
Proline-rich region; SH2: Src homology-2 domain; RH: RIN homology domain; RA: 
Ras association domain.  
 
Currently identified putative effector proteins of Rab31 include the early 
endosome antigen 1 (EEA1) and the Adaptor protein, phosphotyrosine binding (PTB) 
domain, pleckstrin homology (PH) domain, leucine zipper-containing protein 2 
(APPL2). EEA1 is a tethering factor that is recruited to early endosomes via PI3P 
through its C-terminal FYVE zinc finger domain. It forms a homodimer and mediates 
homo- and heterotypic fusion between endosomes. It has been identified as an 
effector protein for all the Rab5 subfamily members (Simpson et al., 2004; Kauppi et al., 
2002; Simonsen et al., 1998; Lodhi et al., 2007). APPL2 contains an N-terminal Bin-
amphiphysin-Rvs (BAR) domain, which is responsible for its curved structure that 
enables it to aid in membrane curvature. Adiponectin is a key hormone secreted 
mainly by adipose tissue that regulates several aspects of fatty acid and glucose 
metabolism (Yamauchi et al., 2003). Together with insulin, it stimulates the 
translocation of Glut4 to the cell surface and glucose uptake. APPL1 has been shown 
to interact with the adiponectin receptor to stimulate activity, and also with Akt and 
PI3K, two kinases involved in insulin signalling. APPL2 has been shown to be a 
negative regulator by competing with APPL1 for binding, or by sequestering APPL1 
through heterodimer formation (Wang et al., 2009). Rab31 was identified to be a 
binding partner of APPL2 through yeast two-hybrid screening (King et al., 2012), 




Currently, no GAPs have been identified for Rab31, nor have other GEFs or 
effectors been characterised, save for those mentioned above. There thus remains a 
dearth of knowledge about the interacting proteins of Rab31, and the potential roles 
they play in aiding Rab31 in mediating vesicular trafficking. As described in Chapter 
1.1.3, Rab cascades have become of particular interest in the field. A better grasp of 
the interacting proteins of Rab31 would give some insight into the possible interplay 
between Rab31 and other Rabs, perhaps in mediating the ‘handover’ of cargo from 
one Rab-containing compartment to another. A few roles of Rab31 in membrane 
trafficking have currently been explored. As described above, Rab31 is postulated to 
play a role in the cycling of Glut4 in adipocytes (Lodhi et al., 2007). Rab31 was also 
found in oligodendrocytes (Rodriguez-Gabin et al., 2001) and shown in live imaging of 
HeLa cells to be found on M6PR-positive tubulovesicular structures emerging from 
the TGN (Rodriguez-Gabin et al., 2009). While the significance of this in 
oligodendrocytes has not yet been fully determined, it is postulated that the cycling of 
M6PR is important to the trafficking of myelin proteins. In support of this, 
independent of its conformational state, Rab31 was shown to interact with 
Oculocerebrorenal syndrome of Lowe protein (OCRL1), a protein which is mutated in 
Lowe syndrome, a disorder of the nervous system which includes degenerative 
demyelination (Rodriguez-Gabin et al., 2010). Although Rab31 is a member of the Rab5 
subfamily, which have been implicated in endosomal trafficking steps, little is 
currently known about the role of Rab31 in endosomal trafficking. In Chapters 3 to 6 
of this thesis, we describe our attempts to shed further insight on the role of Rab31 in 





1.3 Physiological and pathophysiological activities of Rabs 
Given the variety of ways in which Rabs have been implicated in cellular 
trafficking processes, it is not surprising that Rabs have been linked to many 
physiological and pathophysiological processes and diseases (Mitra et al., 2011). Five 
Rab genes have currently been associated with heritable monogenic diseases. Rab7 
missense mutations underlie Charcot–Marie–Tooth type 2B neuropathy, a peripheral 
nervous system disorder that is believed to be due, in part, to the dysregulation of 
peripherin (a neuronal intermediate filament that has been shown to interact with 
Rab7) (Verhoeven et al., 2003; Cogli et al., 2013). Mutations in Rab18 (whose role in 
trafficking has not yet been clearly defined) cause Warburg micro-syndrome (Bem et 
al., 2011), a rare autosomal recessive genetic disorder characterized by microcephaly. 
Mutations in Rab23, which plays a role in the regulation of sonic hedgehog signalling, 
underlie Carpenter’s syndrome, a rare autosomal recessive disorder associated with 
several congenital malformations (Jenkins et al., 2007; Ben-Salem et al., 2013). Rab27, 
which plays a role in melanosome transport via its effector myosin Va, has been 
implicated in Griscelli syndrome type 2 (Barral and Ramalho, 2002), a recessive 
disorder with pigmentation and immune defects. Mutations in Rab39B, a Golgi-
localised neuronal Rab that may play a role in synaptic maintenance, are responsible 
for X-linked mental retardation (Giannandrea et al., 2010). In addition, Rab38 (mutated 
in the Ruby (red eyed dilution; R) locus of the rat and the homologous chocolate (cht) 
locus of the mouse) has been implicated in the autosomal recessive disorder 
Hermansky-Pudlak syndrome (HPS) (Oiso et al., 2004). Recently, mutations in the 
Rab38 GEF BLOC3 have also been identified, and it is postulated that the resulting 




to play a role, gives rise to some of the symptoms observed in HPS, including 
albinism and impaired platelet function (Gerondopoulos et al., 2012).  
The sections below focus briefly on two other Rab functions and activity 
which are highly relevant to the findings reported in this thesis. 
 
1.3.1 Role of Rabs in cancer 
Rabs have a variety of ways in which they can impact cancer and 
tumourigenesis (Recchi and Seabra, 2012; Chia and Tang, 2009). Conceivably, Rabs can 
mediate mechanisms which promote invasiveness, for example, by aiding in the 
secretion of matrix metalloproteinases (MMP), or by directing integrin trafficking, 
which aid in migration and invasiveness. Rab8, for example, was shown to enhance 
the exocytosis of membrane type 1 (MT1)-MMP (Bravo-Cordero et al., 2007). Rab25 
was shown to coimmunoprecipitate the β1 subunit of α5β1 integrins. Rab25 and 
integrins were shown to colocalise at pseudopodal tips, and overexpression of Rab25 
enhanced cell migration by maintaining an actively recycling pool of vesicles 
containing integrins near the cell surface (Caswell et al., 2007). In a situation of 
malignancy, Rab25 would increase the invasiveness of tumour cells. Consistent with 
this, in patients with ovarian cancer, Rab25 was shown to be amplified, and was 
found in higher levels in later stage tumours (Cheng et al., 2004).  
Rabs also mediate several signalling pathways related to cell survival and 
proliferation. An example would be epidermal growth factor (EGF) signalling, which 
activates the downstream MAPK pathway. Rab5 was shown to enhance the 
endocytosis and degradation of ligand-bound EGFR. Surprisingly, this was translated 
into an enhanced MAPK phosphorylation. Also, Rab5 was found to be overexpressed 




activation of Rab5 promoted tumour progression by enhancing tumour migration and 
invasiveness via its interaction with focal adhesion complexes. By enhancing the 
internalisation of focal adhesion complexes, Rab5 aids in the rapid turnover required 
for focal adhesion assembly and disassembly (Mendoza et al., 2013).  
Another way in which Rabs can influence tumour progression is by promoting 
drug resistance. For example, P-glycoprotein, an energy-dependent drug efflux pump, 
has been shown to be overexpressed in several multi-drug resistant human cancers. 
Rab4, which plays a role in recycling endosomes, interacts with the P-glycoprotein 
and was shown to reduce its surface expression (Ferrándiz-Huertas et al., 2011).  
As such, targeting Rabs could, in the future, become an integral part of the 
arsenal used in cancer therapy, a concept which will be discussed in greater detail in 
Section 7.2.  
 
1.3.2 Role of Rabs in the nervous system 
The nervous system involves a complex network of trafficking processes, by 
virtue of the high rates of secretion of neurotransmitters and other signalling 
molecules from the presynaptic membrane and the internalisation of these signalling 
molecules at the post-synaptic membrane. As such, it is conceivable that Rabs would 
have a large impact on the functioning of the nervous system.  
One way in which Rabs play a role is in the trafficking of postsynaptic 
neurotransmitter receptors. Glutamate receptors are synaptic receptors on the 
postsynaptic compartments of neuronal cells and receive glutamate as an excitatory 
neurotransmitter. Ionotropic glutamate receptors form a ligand-gated, non-selective 
cation channel that open in response to glutamate binding. The α-amino-3-hydroxy-5-




movement of AMPARs in and out of the synaptic membrane modulate the strength of 
the synaptic response. Through a surface crosslinking assay, Rab5 overexpression was 
shown to mediate the internalisation and removal of AMPARs from the membrane, 
resulting in long-term depression which is important for synaptic plasticity. Long-
term depression is believed to selectively weaken synapses in conjunction with long-
term potentiation at other synapses to strengthen memory formation. Neurons 
expressing Rab5 dominant negative mutant Rab5 S34N failed to display long-term 
depression (Brown et al., 2005).  
The proper cycling of synaptic vesicles, which carry neurotransmitters that are 
released at the presynaptic membranes and endocytosed at the postsynaptic membrane, 
also require Rabs. At least 11 Rabs have been found on synaptic vesicles (Pavlos and 
Jahn, 2011). Rab5, for example, was shown to colocalise with synaptophysin, a 
glycoprotein found on the synaptic vesicle (de Hoop et al., 1994). More recently, it was 
shown that mutations in Rabex5, the GEF for Rab5, resulted in defects in release of 
presynaptic neurotransmitters (Sann et al., 2012).   
Rabs are also important to the regulation of neuronal-related growth factor 
signalling. For example, Rab22 was shown to have a role in nerve growth factor 
(NGF) signalling. Binding of NGF induces the internalisation of the NGF receptor 
TrkA into Rab22-containing endosomes. Endosomal signalling of internalised TrkA is 
responsible for neurite outgrowth, as TrkA on the plasma membrane, even if 
autophosphorylated, does not result in concomitant neurite outgrowth. Silencing of 
Rab22 inhibited the internalisation, with the resultant effect of reducing neurite 
outgrowth, in PC12 cells (Wang et al., 2011). This is in contrast to Rab5 and Rab21, 




of endosomes to the degradative pathway. This example also helps illustrate the subtle 
differences between the roles of the various Rab5 subfamily members.  
 Rabs have also been found in non-neuronal cells in the nervous system such 
as the glial cells. There are three main types of glia – the astrocytes, which play a 
main role in the formation of the blood-brain barrier, oligodendrocytes which form 
the myelin sheath, and the microglia which act as immune cells in the otherwise 
immune-privileged central nervous system (CNS). Rab3 was found in astrocytes and 
oligodendrocytes (Madison et al., 1996), while Rab40C was found in oligodendrocytes 
(Rodriguez-Gabin et al., 2004). As yet, the exact functions of these Rabs in the neural 
system are largely unknown (Ng and Tang, 2008). It is conceivable that in 
oligodendrocytes, Rabs play a role in regulating myelination. In astrocytes, vesicular 
trafficking is important to, among other things, the exocytosis of neuropeptides that 
regulate cerebral blood flow, and the regulation of glutamate transporter density at the 
plasma membrane which help to regulate the strength of synaptic signalling (Kreft et 








1.4 Rationale for studies reported in this thesis 
In our lab, we have found Rab31 to be localised to the perinuclear region of 
the cell, colocalising with trans-Golgi network (TGN) markers such as TGN46 (Ng et 
al., 2007). The TGN-localised staining persisted even in cells that overexpressed 
Rab31, indicating the fidelity of Rab31’s TGN localisation. The first part of this thesis 
therefore explores possible mechanisms by which Rab31 is localised.  
We subsequently noted that Rab31 not only localises to the TGN, but also, in 
part, to the endosomal network. Both are major focal points for many vesicular 
transport pathways in the cell (Gu et al., 2001). Rab31 is therefore situated at a 
crossroad of many trafficking steps. Rab31 has been shown to function in Golgi-
endosome trafficking of mannose 6-phosphate receptor (Rodriguez-Gabin et al., 2001; 
Rodriguez-Gabin et al., 2009), but has not been directly implicated in endocytic 
trafficking pathways. However, it is structurally grouped as a member of the Rab5 
subfamily, and it also shares similar GEFs and effectors with other Rab5 subfamily 
members, notably GAPex5 and EEA1 (Lodhi et al., 2007; Mishra et al., 2010). GAPex5 
contains a Ras-GAP domain and also a GEF domain for Rabs, and has been identified 
to bind to EGFR through Cbl, an E3 ubiquitin ligase, upon receptor dimerisation (Su 
et al., 2007). EEA1 participates in endosomal tethering and docking (Mills et al., 2001).  
Given the above possible connections, we investigated how Rab31 would affect the 
trafficking of EGFR, after stimulation with EGF (ligand-bound EGFR). This 
constitutes the second part of this project. Our studies were performed in A431 cells, a 
human epidermoid carcinoma line that has high levels of EGFR expression, and 
subsequently repeated in HeLa cells, as a second cell line to show that the phenomena 
were not specific only to A431. Because endogenous Rab31 levels are low, the cell 




Tissue expression pattern survey in mice revealed Rab31 to be enriched in the 
adult brain. Currently, the reason for the enrichment of Rab31 in the brain, and its 
physiological roles there, are not known.  By co-staining with various markers for the 
different cell types in the brain, we found Rab31 to be enriched in astrocytes rather 
than in oligodendrocytes or neurons. Moreover, in a survey of the mouse embryonic 
brain, we found Rab31 to be enriched in radial glia cells (Ng et al., 2009). Radial glia 
develop into the various progenitor cells that will eventually give rise to the three 
main cell types of the brain. As the animal matures from embryonic stages to the adult 
stage, a population of radial glia cells appear to retain their neurogenic potential in the 
adult brain and become the neural stem cells of the subventricular zone (SVZ) of the 
lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus, the two main 
areas of neurogenesis in the adult. Given Rab31’s presence in both GFAP-positive 
cells in the adult brain and radial glia cells in the embryonic brain, we sought to 
determine what role Rab31 might possibly play in the brain, especially in light of the 
role of these cells in neurogenesis. This investigation was further fuelled by our 
findings from the second part of this study, that Rab31 plays a role in the trafficking 
of EGFR, which is an important signalling component in neurogenesis and 
differentiation. The third part of the project therefore looks at the physiological role of 





2. Materials and Methods 
2.1 Gene constructs 
Human Rab31 (IMAGE clone: 4792577), Rab22 (IMAGE clone: 3907891), GAPex5 
(IMAGE clone: 40083103) and RIN3 (IMAGE clone: 30332851) expressed-sequence 
tags were obtained (Research Instruments, Singapore). Mouse Rab31 was kindly 
provided by Prof Mitsunori Fukuda (Tohoku University, Japan). pmCherryC1-Rab5a 
from the laboratory of Prof Christien Merrifield (National Centre for Scientific 
Research, France) was obtained from Addgene (Cambridge, MA, USA) (Plasmid No. 
27679). pCI-Neo Rab11 was constructed from Rab11 cDNA kindly provided by Prof 
Mary McCaffrey (University College Cork, Ireland). Thu dominant negative mutant 
Rab31 S19N was generated by Dr Ng Ee Ling (National University of Singapore, 
Singapore) using nested primers carrying the mutation (Ng et al., 2007).  
The primers below were used to generate the following Rab31 mutants: 
Rab31 mutant lacking hypervariable region (amino acids 165-192): 
Forward: 5’ CTC GAATTC A ATG ATG GCG ATA CGG GAG CTC 3’  
Reverse: 5’ CTT GTC GAC TCA ACA GCA GCG GCT GAT TCC TTG AAA GAG  
               CTC TTC GAT ATT AGC 3’ 
Rab31 mutant lacking prenylation region (C terminal cysteines amino acid 193-
194):  
Forward: 5’ CTC GAATTC A ATG ATG GCG ATA CGG GAG CTC 3’ 
Reverse: 5’ CCT GTC GAC TCA GGC TTG CAT GGT TGG CTT CTC AAC TTT  
               GAT TGT TCC 3’ 
Table. 2.1. Primers used to generate various Rab31 mutants 
 
Constructs were inserted into various vector backbones, including pCI-Neo (Promega, 
Madison, WI, USA), pmCherry-C1 (Clontech, CA, USA), pEGFP-C1 (Clontech) and 






Rabbit anti-sera against Rab31 was generated by repeated immunization of New 
Zealand white rabbits with glutathione-S-transferase (GST) fused to the C-terminal 37 
amino acids of human Rab31. Mouse monoclonal antibody against Rab31 was 
obtained from Abmart (Shanghai, China). The following commercial primary 
antibodies were used: neuronal marker, bIII-tubulin (TuJ) (Research Diagnostics, 
Flanders, NJ, USA), oligodendrocyte marker, 2’, 3’-cyclic nucleotide 3’-
phosphodiesterase (CNPase) (Abcam, Cambridge, UK), astrocyte marker, glial 
fibrillary acidic protein (GFAP) (Sigma–Aldrich Pte. Ltd., Singapore), progenitor cell 
marker, nestin (Chemicon International, Inc., Temecula, CA, USA), proliferating cell 
nuclear antigen (PCNA) (Abcam), immature neuronal marker, doublecortin (DCX) 
(Santa Cruz Biotechnologies, Dallas, TX, USA), EGFR (Merck Millipore, 
Singapore), the cation-independent M6PR (Abcam), early endosome antigen 1 
(EEA1) (BD Biosciences, San Jose, CA, USA), GAPex-5 rabbit polyclonal antibody 
(Abcam), RIN3 (Abnova, Taipei, Taiwan), the trans-Golgi marker TGN46 (AbD 
Serotec, Kidlington, UK), cis-Golgi marker GM130 (BD Transduction Laboratories, 
San Jose, CA, USA),  Rab11 (Abcam), Rab5 (BD Transduction Laboratories) and γ-
tubulin (Sigma). The CD63 hybridoma H5C6 monoclonal antibody developed by J.T. 
August and J.E.K. Hildreth was obtained from the Developmental Studies Hybridoma 
Bank developed under the auspices of the NICHD and maintained by The University 
of Iowa, Department of Biology, Iowa City, IA 52242. The following secondary 
antibodies were used for western blotting: horse radish peroxidase (HRP)-conjugated 
anti-mouse and anti-rabbit antibodies (All Eights Pte. Ltd., Singapore). The following 
secondary antibodies were used for immunofluorescence: Fluorescein isothiocyanate 




anti-goat antibodies (All Eights Pte. Ltd., Singapore).  Dilutions of primary antibodies 
used for Western blots are 1:1000 in 3% bovine serum albumin (BSA) in PBS-T 
(0.05% Tween-20 in phosphate buffered solution (PBS)). Secondary antibodies are 
used at 1:5000 in 5% skimmed milk (Anlene) in PBS-T. For immunofluorescence 
studies primary antibodies are used at 1:50 to 1:100 dilution, and secondary 
antibodies at 1:100 dilution, in blocking buffer consisting of 5% fetal bovine serum 
(FBS) and 2% BSA in PBS. 
 
2.3 Cell culture and transfection 
A431 and HeLa cells (ATCC) were typically seeded at 5 x 104 cells/cm2 density in 
high-glucose Dulbecco Modified Eagle medium (DMEM) (Hyclone, Logan, UT, 
USA) supplemented with 10% heat-inactivated FBS (Hyclone), 1% 
antibiotic/antimycotic (Invitrogen, Carlsbad, CA, USA) and 1 mM sodium pyruvate 
(Invitrogen). Transfection was performed with Lipofectamine 2000 (Invitrogen) or 
XtremeGENE HP DNA transfection reagent (Roche Diagnostics, Alameda, CA, USA) 
according to the manufacturer’s protocols. Stably transfected cells were selected with 
1.2 mg/ml G418 (Invitrogen), and single-cell cloned. 
 
2.4 Primary mouse neural progenitor cell (NPC) culture 
All experiments were approved by the Institutional Animal Care and Use Committee 
(IACUC) and animals were treated in accordance with the IACUC guidelines in an 
Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) 
approved animal facility. NPC isolation was performed from established protocols 
with modifications (Chojnacki and Weiss, 2008; Low et al., 2012). In brief, brains of E15 




was dissected from the brains, dissociated, and cultured in suspension in culture 
media comprising Dulbecco's Modified Eagle Medium/nutrient mixture F-12 
(DMEM/F12) (Hyclone), 0.66% glucose, 2 mM glutamine, 14.6 mM NaHCO3, 5 mM 
HEPES buffer, 23 μg/ml insulin, 93 μg/ml transferrin, 19 nM progesterone, 56 nM 
putrescine, 21 nM sodium selenite, 2% B27 (Invitrogen), 5 ng/ml fibroblast growth 
factor (FGF)-2 (Peprotech, Rocky Hill, NJ, USA)  and 20 ng/ml EGF (Peprotech). 
After 5 days, the neurospheres formed in culture were dissociated into single cells 
using Accutase (Invitrogen) and plated at 2.5 x 104 cells/cm2 density on poly-D-lysine 
(PDL) and laminin (Sigma) coated plates or coverslips, and maintained in 
DMEM/F12 supplemented by 1% N2 supplement (Invitrogen), 1% 
penicillin/streptomycin (Invitrogen) and 1 mM l-glutamine (Invitrogen), FGF-2 and 
EGF, both at 20 ng/mL and 5 μg/mL heparin (Merck). Cells were induced to 
differentiate by culturing for 5 days in different cell culture medium.  Astrocyte 
differentiation medium consisted of DMEM/F12 supplemented with L-glutamine, N2 
supplement, 1% FBS (Hyclone) and 10 ng/mL platelet derived growth factor-bb 
(PDGFbb) (Peprotech). Neuronal differentiation medium consisted of DMEM/F12 
supplemented with L-glutamine, N2 supplement, B27 supplement and 5 ng/mL FGF-
2.  
 
2.5 Expression silencing  
siRNA-mediated silencing was carried out by Lipofectamine RNAiMAX 
(Invitrogen)-mediated transfection of two 27-mer RNA duplexes (Integrated DNA 
Technologies, Inc., Coralville, IA, USA), according to the manufacturer’s protocols. 





































5’ – rGrUrArCrUrArCrArGrArGrGrArGrCrArCrArArGrCrArGCC -3’ 
 
5’ – rCrCrCrArCrArCrArArCrCrArArCrCrArGrGrArArUrCrAGT- 3’ 
 
Table. 2.2. siRNA designed for silencing experiments 
 
Rab31 depletion was also performed using HuSH 29-mer shRNA (Origene, Rockville, 
MD, USA) transfected into cells.  
 
2.6 Retroviral transduction  
Engineered murine retroviruses were made to express GFP along with the shRNA. 
GFP expression was under the control of EF1α promoter and shRNA against Rab31 
was co-expressed under the control of human U6 promoter in the same vector, kindly 
provided by Dr. Eyleen Goh and Ms. Heidi Liou (Duke-NUS Graduate Medical 
School, Singapore). Engineered retroviruses were produced by co-transfection of 
retroviral vectors and vesicular stomatitis virus G glycoprotein (VSVG) into 




resuspended in PBS. NPCs were plated together with retroviruses and assessed for 
GFP expression and knockdown after 2 days.  
 
2.7 Reverse-transcription and real-time PCR 
Total RNA was harvested from approximately 2 x 106 cells using Qiagen RNA 
isolation kit (Qiagen, Singapore). One-step RT-PCR was performed using Qiagen RT-
PCR kit (Qiagen) on 0.5 μg total mRNA. The following thermal cycling parameters 
were used: 50°C at 30 min for reverse transcription, and 95°C at 15 min for activation 
of DNA polymerase. This was followed by 35 cycles of PCR: 94°C at 1 min for 
denaturation of template, 60°C at 1 min for annealing, and 72°C at 1 min for 
extension. The products were run on a 1% agarose gel and visualised.  
For real-time PCR, cDNA was synthesised from total RNA using random hexamers 
from the TaqMan Reverse Transcription Reagent (Applied Biosystems) according to 
the manufacturer’s protocols. The following thermal cycler parameters were used: 
25˚C for 10 min to allow annealing, 48˚C for 40 min for extension of first strand 
cDNA synthesis, 95˚C for 5 min for inactivation of reverse transcriptase, then held at 
25˚C.  Real-time PCR with SYBR green detection (Applied Biosystems) was 
performed using ABI Prism 7000 Sequence Detection System (Applied Biosystems). 
Appropriate non-template controls were included and dissociation analysis was 
performed at the end of each run to confirm the specificity of the reaction. The 
following thermal cycling parameters were used: 95˚C for 10 min, for activation of 
AmpliTaq Gold DNA Polymerase, followed by 40 PCR cycles of 95˚C for 15 sec for 
denaturation and 60˚C for 1 min for annealing and extension. The threshold cycle (CT), 




the threshold, was set automatically by the software. Expression levels compared to 
the 0 hour were analysed using the 2 -ΔΔCT method. 
 
The following primers used for amplification are shown in Table. 2.3. Glyceraldehyde 
3-phosphate dehydrogenase (G3PDH) was used as the reference gene. 
Rab5a Forward: 5’ CGC GAA TTC ATG GCT AGT CGA GGC GC 3’ 





Forward: 5’ CTC GAATTC A ATG ATG GCG ATA CGG GAG CTC 3’  
Reverse: 5’ TCG GTCGAC TCA ACA GCA CCG GCG GCT 3’ 
Mouse 
Rab31 
Forward: 5’ CAC TAA GCA GGA TTC ATT TCA TAC C 3’  




Forward: 5’ GTC GAA TTC ATG GTG AAA CTA GAT ATT CAT ACT CTG 3’  
Reverse: 5’ CCT CCC ATC AAC AAA TTG TGT ATC TTC 3’  
 
RIN3 Forward: 5’ GCG GAA TTC A ATG ATC CGA CAC GCC GGG GCG 3’ 
Reverse: 5’ CTA GCC ACC ACC CGG TGC AGG ATC 3’ 
 
GFAP Forward: 5’AAC AAC CTG GCT GCG TAT AG 3’ 
Reverse: 5’ TCT CGA ACT TCC TCC TCA TAG AT 3’ 
 
Nestin Forward: 5’AGA AGC AGG GTC TAC AGA GT 3’ 
Reverse: 5’ TCC AGC AGA GTC CTG TAT GTA 3’ 
 
G3PDH Forward: 5’ ATC TTC CAG GAG CGA GAT CC 3’ 
Reverse: 5’ AGA GGG GGC AGA GAT GAT GA 3’ 
 
Table. 2.3. Primers designed for PCR. 
 
 
2.8 EGF pulse-chase experiments 
Cells were serum starved overnight in basal DMEM. 0.25 µg/mL to 0.5 µg/mL TxR 
or FITC-tagged epidermal growth factor (EGF) (Molecular Probes, Invitrogen Corp. 
(Carlsbad, CA, USA) or non-conjugated EGF (Peprotech) was incubated with cells on 
ice for 20 min, followed by a 5 min incubation at 37°C for internalisation. Cells were 
then acid washed (150mM NaCl, 50mM glycine) before being returned into complete 





2.9 Collection of cell lysate and Western blot 
For Western immunoblot analysis, tissue from Sprague-Dawley rat or cells from 
mammalian cell culture were lysed with lysis buffer (50 mM Tris pH8, 1 mM EDTA 
pH8, 150 mM NaCl, and 1% Triton X-100 with protease inhibitor cocktail (Roche) 
for 60 min. Lysates were then subjected to reducing sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), electroblotted onto Hybond C-extra 
(Amersham Biosciences, UK) nitrocellulose membranes and probed with the 
respective antibodies. Band densities were quantified using Image J (US NIH, 
Bethesda, MD, USA), as a means of calculating the relative protein levels present.  
 
2.10 Immunocytochemistry, immunohistochemistry, and immunofluorescence 
microscopy 
For immunohistochemistry, 4% paraformaldehyde-perfused embryonic and postnatal 
mice brain tissue were optimal cutting temperature (OCT) (Electron Microscopy 
Sciences, Hatfield, PA, USA)-embedded and sectioned by cryostat at 20 μm thickness 
(Leica Microsystems, Wetzlar, Germany). Fluorescence labelling of tissue 
cryosection was performed with various antibodies and visualised with Carl Zeiss 710 
(Oberkochen, Germany) confocal imaging system. For immunofluorescence 
microscopy, cells plated on cover slips and subjected to various treatments were fixed 
with 4% paraformaldehyde followed by sequential incubation with the primary and 
secondary antibodies. Fluorescence labelling was visualized using the Carl Zeiss 710 
confocal imaging system. Images were collected in separate z sections and final 
images presented are typically from collapsed z stacks. Image processing was done 




2.11 Live-cell imaging 
Cells expressing EGFP-Rab31 were grown on 35 mm glass-bottomed dishes (Ibidi, 
Germany) and treated with EGF-TxR as described above. Timelapse imaging on a 
single plane was performed at various intervals using LSM710 confocal microscope 
(Carl Zeiss, Germany), at a scanning speed of 2.5s per frame.  
 
2.12 Flow cytometry  
Cells were collected and fixed for 15 min in 2% paraformaldehyde. 1 x 105 cells were 
resuspended in blocking/incubation buffer (0.5% bovine serum albumin (BSA) in 
PBS) for 10 min, followed by subsequent incubation with FITC-labelled anti-EGFR 
antibodies (Cell Signalling Technology, Beverly, MA, USA) at 4°C, overnight. 1 x 
104 cells were analysed using BD FACSCanto II Flow Cytometer (BD Biosciences) 
and histogram displaying count of fluoresecent intensity was presented using Flowing 
Software 2 (Turku Centre for Biotechnology, Finland).  
 
2.13 Glycerol gradient sedimentation  
Samples were lysed with lysis buffer containing 10 mM HEPES, 2 mM MgCl2, 10 
mM KCl, 0.5 mM EDTA, 150 mM NaCl and 1% TritonX-100. Samples were treated 
with or without GTPγS (Merck Millipore) and diluted to a final solution containing 
0.5% TritonX-100. 2 mg of lysate was loaded with onto 11 mL 5-45% glycerol 
gradients. Centrifugation was for 18 h at 38 000 r.p.m.in a Beckman SW41Ti rotor 
maintained at 4°C. 1 mL Fractions were collected and proteins were precipitated in 20% 
trichloroacetic acid (TCA), followed by cold acetone wash. Standard protein markers 




2.14 Co-immunoprecipitation  
To analyse interacting partners of Rab31, 2 µg of Rab31 antibody was incubated at 
4ºC overnight with 1 mg cell lysate loaded with 1 mM GTPγS at room temperature 
for 20 min, then bound to 50 µl Protein A beads (GE Healthcare, Singapore). After 
incubation, beads were washed with ten column volumes of lysis buffer. Elution of 
bound proteins was performed with loading buffer at 72ºC. Eluted proteins were 
analysed by SDS–PAGE and Western blot.  
 
2.15 GST affinity pulldown assay 
GST-fusion proteins of the Rabs were expressed in Escherichia coli DH5α or BL21-
DE3 cells and purified by standard protocols. In brief, cells were harvested by 
centrifugation, resuspended and sonicated. The supernatant was incubated with 
glutathione beads (GE Healthcare) and eluted in elution buffer consisting of 50 mM 
Tris pH8, 0.1% TritonX-100, and 20 mM glutathione. To perform affinity pull-down 
of interacting partners, GST–Rab31 was added to 1 mg cell lysate and loaded with 1 
mM GTPγS at room temperature for 20 min, then bound to 50 µl glutathione beads 
overnight at 4°C. After incubation, beads were washed with ten column volumes of 
lysis buffer. Elution of bound proteins was performed with loading buffer at 72°C.  
 
2.16 Statistical analysis 
Images and data presented in this thesis are typically representative of at least 3 
independent experiments. Statistical analysis was performed using unpaired Student’s 
t-test and one-way analysis of variance (ANOVA) as appropriate. Data shown in bar 
graphs usually represent means of 3 independent experiments assayed in triplicate. 




3. Domains and interactions responsible for the subcellular localisation of Rab31 
3.1 Chapter Introduction: Localisation of Rab proteins to distinct membranes 
As discussed in Section 1.1.2, a variety of mechanisms exist which aid in the 
localisation of Rabs to specific membranes. Newly synthesised Rabs are post-
translationally modified by prenylation (Pereira-Leal et al., 2001), after which Rabs can 
be inserted into membranes. At the membranes, Rabs are activated by GEF-mediated 
GDP-GTP exchange, and engage effector proteins. GAPs enhance the GTPase 
activity of the Rabs, thus inactivating them (Nottingham and Pfeffer, 2009). GDP-bound 
Rabs can be extracted from the membrane by GDP dissociation inhibitors (GDI) 
(Ullrich et al., 1993; Ullrich et al., 1994; Soldati et al., 1994). Several mechanisms, based 
both on Rab structure and Rab interacting proteins, participate in targeting Rabs to 
their specific membranes / organelles. Structural domains such as the Rab 
hypervariable domain and the prenylation domain have been shown to be important 
for membrane association. Interacting proteins such as GDIs and GDI displacements 
factors (GDF) have also been shown, in some cases, to carry information on 
subcellular membrane specificity. Activating proteins, such as GEFs, may also be 
responsible for the specific membrane localisation of some Rabs, while effector 
proteins may also interact with Rabs and hold them in specific microdomains. Lastly, 
inactivating proteins such as GAPs may work to negatively regulate Rabs and 
delineate membrane regions which Rabs cannot be present.  
As a whole, there therefore appears to be a wide variety of mechanisms for 
targeting Rabs to their specific membranes, which may vary for different Rabs. In the 
course of our experiments, we have observed that Rab31 appeared to be rather 
faithfully targeted to the trans-Golgi network (TGN) even when transiently 




sought to identify which mechanisms might be important for this specific targeting of 
Rab31.  
 
3.2 Results: Dependence of Rab31 subcellular localisation on functional domains  
To identify regions within Rab31 that might be responsible for its subcellular 
localisation, we created Rab31 mutant constructs lacking either the hypervariable 
domain (ΔHV) or the prenylation domain (ΔGG) (Fig. 3.1A and B). We first sought 
to identify if the HV region of Rab31 was important for Rab31 membrane localisation. 
Since Rab22, a  close homologue of Rab31, although almost identical in sequence to 
the latter except for the HV region (Fig. 3.1C) (Chen et al., 1996),  is localised to 
endosomes rather than the TGN, we rationalised that the HV region might contain 
information about the TGN specific localisation of Rab31. While wild-type Rab31 
strongly colocalised with the TGN marker TGN46 (Fig. 3.2 first panel) in A431 cells, 
we found that the Rab31 mutant, Rab31 ΔHV, was visibly cytosolic with some 
nuclear staining (Fig. 3.2 second panel). This is in line with observations by Chavrier 
et al. (1991), and suggests perhaps that for the Rab5 subfamily, the HV region is 
important for correct protein folding and post-translational modification for 
membrane insertion. Further biochemical studies to investigate if Rab31 ΔHV was 
correctly prenylated would serve to shed further light on this.  
We next sought to identify if the C-terminal cysteine residues for prenylation 
was important for Rab31 membrane localisation. We rationalised that if interactions 
with GEFs or effector proteins were responsible for targeting and holding Rab31 in a 
microdomain on the TGN, soluble Rab31 might still be found associated with the 
TGN membrane despite its lack of prenylation. We created a Rab31 truncation mutant 




ΔGG, was cytosolic (Fig. 3.2 third panel). This suggests that interactions with TGN-
localised GEFs or effectors, if any, were not sufficient to hold Rab31 at the TGN. 
This was corroborated by looking at the localisation of the dominant negative Rab31 
S19N mutant, which is unable to exchange GDP for GTP. As such, the S19N mutant 
can be expected to engage its GEF without releasing it. We found that Rab31 S19N, 
like Rab31 ΔGG, was also cytosolic (Fig. 3.2 fourth panel), suggesting that 
interaction with GEF proteins is not sufficient to localise Rab31 to the TGN. 
Prenylation of Rab31 may still be critical for membrane localisation, perhaps because 
Rab31 must first be inserted into membranes before functional association with 











Fig. 3.1. Rab31 and its mutants 
A) Rab31 mutant constructs were expressed in pDMyc expression vector (see 
Appendix 1 for vector map).  
B) A431 cells were transfected with the various Rab31 mutant constructs as indicated 
and the wild type and various mutant proteins were analysed after 48 h by SDS-PAGE 
and Western blot using anti-Myc antibodies. WT: Rab31 wild type protein; ΔHV: 
Rab31 mutant lacking the HV domain (amino acids 165-192); ΔGG: Rab31 mutant 
lacking the prenylation domain (Cysteines 193 and 194); S19N: Rab31 dominant 
negative mutant incapable of GDP-GTP exchange.  
C) Amino acid sequence alignment of Rab31 and Rab22 
Amino acid sequences of Homo sapiens Rab31 and Rab22 were aligned using NCBI’s 
Blast program. SWI: Switch I region; SWII: Switch II region. Green box highlights 







Fig. 3.2. Subcellular localisation of Rab31 and its mutants 
A431 cells were transfected with the various Rab31 mutant constructs as indicated 
and observed after 48 h. Cells were fixed and immunostained for Myc-tagged Rab31 
(green) and TGN46 (red). Nuclei are visualised with Hoechst 33342 stain. Scale bar = 








3.3 Results: Dependence of Rab31 subcellular localisation on interacting proteins  
Dependence on GEFs 
Although the experiments above suggested that interaction with GEF proteins 
were not sufficient to localise Rab31 to the membrane, we asked whether GEF 
proteins were at all necessary for Rab31’s localisation. Two GEFs have been thus far 
identified for Rab31 – GAPex5 and RIN3. GAPex5 was first confirmed as a Rab31 
GEF in studies looking at Glut4 trafficking. RIN3 was identified more recently as 
another Rab31 GEF. It has higher GEF activity for Rab31 than for the other Rab5 
subfamily proteins such as Rab5 and Rab22 (Kajiho et al., 2011). A specific role for 
RIN3 has not yet been found.  
We found that depletion of GAPex5 resulted in a dispersal of Rab31 from the 
TGN, as seen by a delocalisation with the trans-Golgi marker TGN46 (Fig. 3.3). This 
dispersal from the TGN did not result in an accumulation in other vesicular 
compartments, but instead suggested that the membrane association of Rab31 was 
affected. Interestingly, the same phenomenon was not observed when RIN3 was 
silenced (Fig. 3.3), as Rab31 remained largely at the TGN. Taken together, the results 
suggest that GAPex5 contributed to the TGN localisation of Rab31, and this was not 
due solely to its action as a GEF to activate Rab31, since RIN3 deficiency did not 







Fig. 3.3. Depletion of GAPex5 but not RIN3 disrupts Rab31 localisation to the TGN  
A) A431 cells stably expressing EGFP-tagged Rab31 were transfected with Scrambled 
(Scr), GAPex5, or RIN3 siRNA, and assayed after 48 h. Cell lysates were analysed by 
Western blot for GAPex5 knockdown and RT-PCR for RIN3 knockdown. Band 
density of RIN3 was 90% reduced and GAPex5 was 70% reduced upon siRNA-
mediated knockdown.   
B) Cells were fixed and immunostained for localisation of EGFP-Rab31 (green) and 
TGN46 (red). Scale bar = 20 μm.  
C) Colocalisation between EGFP-Rab31 and TGN46 was quantified using Zen 2010 
software for calculation of the Overlap Coefficient. 27 cells in 3 independent 
experiments were analysed and data is shown as mean ± SEM. *P<0.05 as determined 








In our survey on the effect of GAPex5 depletion on Rab31, we have used 
various antibody markers to label the different endosomal compartments, including 
the early endosomal marker EEA1. Interestingly, we observed that while Rab31 was 
largely TGN localised, there were a few Rab31 puncta colocalising with EEA1, 
suggesting that a percentage of Rab31 was also found in early endosomes. This is in 
line with the fact that EEA1 has been identified as an effector protein for Rab31, and 
is important for its role in EGFR trafficking (see Chapter 5). When GAPex5 was 
silenced, this colocalisation was also lost (Fig. 3.4). 
 
Fig. 3.4. Rab31 and its early endosomal localisation is lost when GAPex5 is silenced  
A431 cells stably expressing EGFP-Rab31 were transfected with Scrambled (Scr) or 
GAPex5 siRNA and assayed after 48 h. Cells were fixed and immunostained for 
localisation of EGFP-Rab31 (green) and EEA1 (red). Arrowheads indicate some of 






Because of the different effects of GAPex5 and RIN3 deficiency on Rab31’s 
membrane association, we explored the localisation of these GEFs themselves. We 
hypothesised that GAPex5 might be localised at the TGN, therefore enabling Rab31 
to be localised there, whereas RIN3 might not. However, we found that GAPex5 
staining was largely cytosolic (Fig. 3.5), when expressed in A431 cells. This is in line 
with observations by other groups, which found that endogenous GAPex5 in HeLa 
cells is cytosolic as well as on plasma membrane and endosomes (Hunker et al., 2006). 
As such, how GAPex5 can play a role in the membrane localisation of Rab31 remains 
to be determined. Unexpectedly, we found that RIN3 was localised to the TGN (Fig. 
3.6). This is in contrast to previous studies which suggested that RIN3 was largely 
cytosolic (Kajiho et al., 2011). The difference in observation may be due to the fact that 
in the study by Kajiho et al., RIN3 was overexpressed, whereas in A431 cells the 
endogenous RIN3 levels were detectable by our RIN3 antibody.  
 
 
Fig. 3.5.GAPex5 is cytosolic and does not colocalise with Rab31 or TGN46 
A431 cells were transfected with GAPex5 and immunoassayed after 48 h for GAPex5 







Fig. 3.6. Rab31 and RIN3 localise to the TGN  
EGFP-Rab31 (green) was stably expressed in A431 cells. Cells were fixed and 




Dependence of Rab31 membrane localisation on effectors 
  Lastly, we checked if the depletion of a Rab31 effector protein, Early 
endosome antigen 1 (EEA1), would affect its subcellular localisation. We found that 
depletion of EEA1 did not affect the TGN localisation of Rab31 (Fig. 3.7). Because of 
the already low levels of colocalisation between Rab31 and EEA1, and the lack of a 
stable early endosome marker besides EEA1, we were unable to determine if EEA1 
depletion also reduced the presence of Rab31 on the early endosome.  
 Another recently identified effector for Rab31 is the Adaptor protein, 
phosphotyrosine binding (PTB) domain, pleckstrin homology (PH) domain, leucine 
zipper-containing protein 2 (APPL2). APPL2 is found on the plasma membrane and 
in the cytosol (Wang et al., 2009). Its depletion also did not affect Rab31 localisation 







Fig. 3.7. Depletion of EEA1 does not disrupt localisation of Rab31  
EGFP-Rab31 (green) was stably expressed in A431 cells. Cells were treated with 
scrambled (Scr) or EEA1 siRNA and assayed after 48 h. EEA1 was depleted by 80% 
as quantified by Western blot. Cells were fixed and immunostained for TGN46 (red) 
and EEA1 (pseudo-coloured blue). Merged panels show EGFP-Rab31 and TGN46. 
Scale bar = 20 μm.  
 
 
Fig. 3.8. Depletion of APPL2 does not disrupt localisation of Rab31  
EGFP-Rab31 (green) was stably expressed in A431 cells. Cells were treated with 
scrambled (Scr) or APPL2 siRNA and assayed after 48 h. APPL2 was depleted by 
50% as quantified by Western blot. Cells were fixed and immunostained for TGN46 






3.4 Chapter Discussion: Factors influencing Rab31 subcellular localisation  
We have shown that a) an intact HV domain, b) an intact C-terminal 
prenylation region, and c) the GEF GAPex5 are necessary for the localisation of 
Rab31 to the TGN/endosomal membrane. At the same time, however, any of the 
above alone are not sufficient to determine the correct membrane localisation of 
Rab31, as the GDP-locked Rab31 dominant negative mutant Rab31 S19N, which has 
an intact HV and GG domain and is able to engage GAPex5, is also not membrane 
localised. This might suggest that Rab31 must be able to go through the cycle of 
GDP-GTP exchange, and perhaps engage some as-yet-unknown cognate effector, to 
be correctly localised to the TGN membrane. While the effectors EEA1 and APPL2 
do not appear to be necessary for Rab31 localisation, it must be noted that the 
knockdown in these studies were not complete (80% for EEA1 and 50% for APPL2), 
and further analysis may be required. It may also be that only one (as yet unidentified) 
‘key’ effector is responsible, as suggested by the observations of Aivazian et al. (2006) 
where only the effector TIP47 but not the effector p40 is responsible for Rab9 
localisation. As yet, there have not been other well-characterised interacting proteins 
of Rab31, especially those found on the TGN that could serve as anchors. As further 
work reveals more candidate Rab31-interacting proteins, we may be able to further 
explore this. Amongst the Rab31-interacting proteins that remain to be identified 
would also include putative Rab31 GAPs. At present, only two Rab31-interacting 
proteins, identified via a GST pulldown assay, have been shown to have the putative 
RabGAP TBC domain (Kanno et al., 2010). A direct role for these proteins serving as 
Rab31 GAPs has not been shown. 
One interesting observation was that it was the deficiency of a specific GEF, 




silencing was incomplete (90% reduction for RIN3 and 70% for GAPex5), the results 
suggest that GAPex5 had a greater impact on Rab31 membrane localisation than 
RIN3. What would be the reason for the difference in effect between depletion of 
GAPex5 and RIN3? One reason could be that GAPex5 is the major GEF for cellular 
Rab31, whereas RIN3 may not have an extensive role. RT-PCR suggests that GAPex5 
transcripts are more abundant than RIN3, in A431 cells at least (Fig. 3.9).  
 
Fig. 3.9. RT-PCR to compare the endogenous levels of GAPex5 and RIN3 in A431 
cells 
Total mRNA was harvested from A431 cells and RT-PCR was performed using 
specific GAPEx5, RIN3 and G3PDH primers. After 35 cycles, amplified cDNA 
products were resolved on a 1.5% agarose gel and the bands visualised by ethidium 
bromide staining. Transcript of the housekeeping gene G3PDH is also amplified as a 
control. 
 
Depletion of RIN3 therefore may not have as severe an effect as depletion of 
GAPex5 in terms of membrane targeting of Rab31. Also, there has been previous 
evidence to suggest that the various GEFs do not have an equal importance in 
facilitating nucleotide exchange of their target Rabs. For example, Rabex5, GAPex5 
and RIN1 are all known GEFs of Rab5, but have varying efficiencies in terms of Rab5 
GDP-GTP exchange (Kajiho et al., 2011). Another reason could be that different GEFs 
serve different roles in the cell. For example, RIN1 has been shown to be the major 
GEF important for the role of Rab5 in EGFR trafficking (Chen et al., 2009), whereas 
Rabex5 has been implicated in other functions of Rab5 such as stabilising the Rab5 




localisations in A431 cells, they likely have different principle roles. GAPex5, as the 
predominantly cytosolic GEF, may be in a better position to activate newly 
synthesised cytosolic Rab31. Once in its active state, Rab31 may then be able to 
interact with various other effector proteins at the TGN and form a microdomain. A 
third reason could be that the activity of GEFs themselves could be regulated by other 
events such as activation of signalling proteins triggered by external stimuli. For 
example, RIN3 could have regulatory domains that suppress GEF activity until 
stimulated; RIN3 may thus act as a GEF only in response to specific events. An 
example of this can be found in the Rab5 GEF Rabex5, in which the coiled-coil 
domains act as an autoinhibitory element that is relieved only upon binding to 
Rabaptin5 (Delprato and Lambright, 2007). 
Taken together, the results do suggest that the presence of Rab31 on the TGN 
at steady state is a multifactorial process. Rab31 S19N, because it cannot exchange 
GDP for GTP, is perhaps unable to engage the effector proteins that would localise it 
to the TGN. Meanwhile, disruption of the HV and/or prenylation region may affect 
the binding of Rab31 to GAPex5. For this reason, our Rab31 truncation mutants are 
therefore not colocalised to the TGN. In our hands, we have been unable to isolate 
Rab31 and GAPex5 as a complex by co-immunoprecipitation, perhaps because of the 
transient nature of the interaction, or the inadequacies of the antibodies to co-
immunoprecipitate. We were thus unable to verify if the ΔHV and ΔGG mutants were 
able to engage GAPex5.  
Finally, we note the interesting observation of the presence of a small amount 
of Rab31 on the EEA1-containing endosomes. This may simply be part of a cycling 
of TGN-residing proteins or perhaps triggered by an external signalling event. It is 




and may suggest that Rab31 also has a role in endosomes. Results presented in the 




4. Role of Rab31 in EGFR trafficking  
4.1 Chapter Introduction: Rab proteins in trafficking of cell surface receptor 
EGFR  
As described in Section 1.2.2., many Rabs, including those of the Rab5 
subfamily, have been implicated to varying extents in various steps of the EGFR 
trafficking pathway. For example, Rab5 (Huang et al., 2004) and Rab 21 (Simpson et al., 
2004) have been shown to enhance the movement of EGFR from the cell surface into 
early endosomes, while Rab22, and also Rab21, have been implicated in the later 
trafficking steps, with a general role in recycling or terminating the EGFR signalling 
in late endosomes / lysosomes (Kauppi et al., 2002). In some studies, loss of Rab5 
activity (either by siRNA or use of dominant negative Rab5) has also bee n shown to 
inhibit the exit of ligand-bound EGFR from the early endosome (Chen et al., 2009; 
Dinneen and Ceresa, 2004). Meanwhile, another Rab, Rab7, has been linked to the 
maturation of late endosomes carrying EGFR to lysosomes (Vanlandingham and Ceresa, 
2009).  
Rab31 has been shown to function in Golgi-endosome trafficking of mannose 
6-phosphate receptor (Rodriguez-Gabin et al., 2001; Rodriguez-Gabin et al., 2009), but has 
not been directly implicated in endocytic trafficking pathways. As shown in Chapter 3, 
Rab31 is localised to the perinuclear region of the cell, colocalising with trans-Golgi 
network (TGN) markers such as TGN46 (Ng et al., 2007). The TGN compartment is a 
major focal point for many vesicular transport pathways in the cell (Gu et al., 2001). 
Given its subcellular location at the TGN, Rab31 is therefore situated at the 
crossroads of many trafficking steps. It also shares similar GEFs and effectors with 
other Rab5 subfamily members, notably GAPex5 and the early endosome antigen 1 




EGFR through Cbl, an E3 ubiquitin ligase, upon receptor dimerisation (Su et al., 2007) 
while EEA1 participates in endosomal tethering and docking (Mills et al., 2001). As 
discussed in Section 3.4, we also found Rab31 localised to early endosomes. Given 
these connections listed above, we investigated if and how Rab31 would affect the 
EGFR trafficking itinerary in cultured A431 cells, a human epidermoid carcinoma 
line that has a high level of EGFR expression. 
 
4.2 Results: Rab31 in endocytosis and degradation of EGFR  
Rab31 affects the endocytic trafficking of ligand-bound EGFR 
By depleting Rab31 in A431 cells, we have previously shown that loss of 
Rab31 inhibits the endocytic traffic of ligand-stimulated EGFR. Rab31 depletion 
delayed the entry of ligand-bound EGFR into late endosomes, as seen by the reduced 
fraction of large EGFR-positive puncta at 60 min post-pulse, and quantified by 
colocalisation with the late endosome marker CD63/Lamp3 (Ng et al., 2009). In 
investigating this phenomenon further, we first ascertained that depletion of Rab31 
did not affect the plasma membrane levels of EGFR, suggesting that we are not 





Fig. 4.1. Depletion of Rab31 does not affect plasma membrane levels of EGFR 
A) Flow cytometry was used to analyse surface EGFR levels of non-permeabilised 
A431 cells, transfected with Scrambled siRNA (Scr) or Rab31 siRNA, and probed 
with FITC-labelled anti-EGFR antibodies. Histogram displaying count of fluorescent 
intensity is given. 
B) A431 cells treated with Scr or Rab31 siRNA were immunostained for EGFR 
(green). No difference in EGFR levels at the plasma membrane was observed. Scale 











We next found that loss of Rab31 did not affect the colocalisation between 
ligand-bound EGFR (as indicated by labelled EGF signal) and EEA1 at 10 min post-
pulse, suggesting that Rab31 is not required for the initial endocytosis step and 
trafficking of ligand-bound EGFR into the early endosome (Fig. 4.2), a role that is 
commonly attributed to Rab5 (Barbieri et al., 2000). Instead, loss of Rab31 resulted in a 
significantly diminished entry of ligand-bound EGFR into the late endosome 
compartment, as there is less colocalisation between ligand-bound EGFR and the late 
endosome marker CD63 at 30 min (Fig. 4.3). This time of 30 min corresponds to the 
transition of the internalised EGFR between early and late endosomes (Liu et al., 2009), 
and suggests that Rab31 is required for early endosome to late endosome transport of 
ligand-bound EGFR. To ascertain that the effect of Rab31 manipulations on endocytic 
traffic of ligand-bound EGFR was not specific only to A431 cells, which have 
exceptionally high levels of EGFR, we also performed similar experiments in HeLa 
cells. As with A431 cells, Rab31 depletion in HeLa cells also inhibited late endosome 







Fig. 4.2. Loss of Rab31 does not hinder early endocytic trafficking of ligand-bound 
EGFR 
A431 cells were transfected with Scrambled (Scr) or Rab31 siRNA, and analysed for 
EGF trafficking after 48 h.  
A) Rab31 was depleted by 85% as assessed by RT-PCR (the endogenous levels of 
Rab31 protein is low and Western blot analysis was not useful).  
B) Cells were pulsed with 0.5 μg/mL EGF-FITC (green) followed by a 10 min chase 
before fixation and immunofluorescence analysis with the co-labelling of early 
endosome marker EEA1 (red). The individual and merged fluorescence signals of the 
areas enclosed in white squares are shown enlarged 2x on the right. Scale bar = 20 
µm.  
C) Number of EGF-FITC puncta positive for EEA1 was quantified and presented 
graphically as a percentage of total EGF-FITC puncta counted. 27 cells in 3 
























Fig. 4.3. Loss of Rab31 hinders trafficking of ligand-bound EGFR to the late 
endosome  
A431 cells were transfected with Scrambled (Scr) or Rab31 siRNA, and analysed for 
EGF trafficking after 48 h. Cells were pulsed with 0.5 μg/mL EGF-TxR (red) 
followed by a 30 min chase before fixation and immunofluorescence analysis with the 
co-labelling of the late endosome marker CD63 (green).  
A) Arrowheads show EGF-TxR puncta colocalising with CD63. Scale bar = 20 µm. 
B) EGF-TxR puncta also positive for CD63 was quantified and presented graphically 
as a percentage of total EGF-TxR puncta counted. 27 cells in 3 independent 
























Fig. 4.4. Loss of Rab31 hinders trafficking of ligand-bound EGFR in HeLa cells to the 
late endosome 
HeLa cells were transfected with Scrambled (Scr) or Rab31 siRNA and analysis was 
performed after 48 h.  
A) Rab31 was depleted by 85% as quantified by Western blot.  
B) Cells were pulsed with 0.5 μg/mL EGF-FITC (green) followed by a chase before 
fixation and immunofluorescence. At 30 min, larger EGF-FITC puncta is observed for 
cells treated with Scr compared to Rab31 siRNA. Scale bar = 20 µm.  
C) Cells were pulsed with 0.5 μg/mL EGF-FITC followed by a 30 min chase before 
fixation and immunofluorescence analysis with the co-labelling of the late endosome 
marker CD63. Number of EGF-FITC puncta also positive for CD63 was quantified 
and presented graphically as a percentage of total EGF-FITC puncta counted. 35 cells 
in 3 independent experiments were analysed and data is shown as mean ± SEM. 






















We asked if an increase in Rab31 levels could have a converse effect on the 
endocytic transport of EGFR. Stable overexpression of Rab31 (Rab31 OE) did not 
affect the steady state levels or plasma membrane localisation of EGFR when 
compared to cells transfected with the vector control (VC) (Fig. 4.5). 
 
Fig. 4.5. Overexpression of Rab31 does not affect plasma membrane levels of EGFR 
A) Flow cytometry was used to analyse surface EGFR levels of non-permeabilised 
A431 cells, overexpressing Rab31 or not, probed with FITC-labelled anti-EGFR 
antibodies. Histogram displaying count of fluorescent intensity is given.  
B) Rab31 was stably overexpressed in A431 cells and immunostained for Rab31 
(green) and EGFR (red). No difference in EGFR levels at the plasma membrane was 
observed between Rab31-overexpressing cells (arrows) and non-expressing cells. 








When the cells were pulsed and chased with EGF-TxR, cells overexpressing 
Rab31 exhibited larger EGF-TxR punctate structures representative of internalised 
EGFR, as observed by immunofluorescence (Fig. 4.6A). The difference was only 
evident at 30 min, not at 10 min post-pulse, suggesting that Rab31 overexpression 
does not impact the initial internalisation of EGFR from the plasma membrane. There 
was significantly more large puncta (>0.25 μm) in the Rab31 OE cells, whereas there 
was significantly more small puncta (<0.05 μm) in the non-overexpressing cells from 
the same population (Fig. 4.6B). Moreover, overexpression of Rab31 increased the 
percentage of EGF-TxR puncta that were positive for CD63 at 30 min (Fig. 4.6C). 
These experiments were repeated in HeLa cells and similar results were obtained (Fig. 
4.7). The results, beyond complementing the Rab31 depletion experiments, suggest 
that Rab31 positively influences the endocytic trafficking of ligand-bound EGFR, and 
that this influence may be proportionately enhanced by increasing Rab31 levels.  
To confirm that Rab31 impacts the endocytic trafficking of ligand-bound 
EGFR to late endosomes, we looked at the eventual degradation of EGFR after an 
EGF pulse. HeLa cells were used as the changes in EGFR levels due to degradation 
were more easily seen in a Western blot due to the more moderate levels of EGFR in 
HeLa cells compared to A431 cells. We found that at 30 min, loss of Rab31 reduced 
the rate at which EGFR is degraded by 14%, while overexpression of Rab31 increased 







Fig. 4.6. Overexpression of Rab31 enhances endocytic trafficking of ligand-bound 
EGFR to the late endosome in A431 cells  
A431 cells were stably transfected with Rab31. Cells were pulsed with 0.5 μg/mL 
EGF-TxR followed by a chase at various time points before fixation and 
immunofluorescence analysis.  
A) Effect of overexpressing Rab31 (asterisks) on the endocytosis of EGF-TxR (red) 
was observed by labelling for Rab31 (green) after 10 and 30 min chases. Scale bar = 
20 μm.  
B) Sizes of EGF-TxR puncta in Rab31 overexpressing (OE) and non-OE cells from 
the same population were quantified using ImageJ, and the size distribution is 
represented graphically as a bar chart. 15 cells in 3 independent experiments were 
analysed and data is shown as mean ± SEM.  *P<0.05 by Student’s t-test.  
C) Number of EGF-TxR puncta also positive for CD63 in Rab31 OE and non-OE 
cells from the same population was quantified and presented graphically as a 
percentage of total EGF-TxR puncta counted. 32 cells in 3 independent experiments 
























Fig. 4.7. Overexpression of Rab31 enhances endocytic trafficking of ligand-bound 
EGFR to late endosomes in HeLa cells  
HeLa cells were stably transfected with mcherry-Rab31. Cells were pulsed with 0.5 
μg/mL EGF-FITC followed by a chase at various time points before fixation and 
immunofluorescence analysis.  
A) Effect of overexpressing mcherry-Rab31 (red) on the endocytosis of EGF-FITC 
(green) was observed after 30 min chase. There are larger puncta in the cell 
overexpressing Rab31 (asterisk) compared to the cells without overexpression. Scale 
bar = 20 μm. 
B) Number of EGF-FITC puncta also positive for CD63 was quantified and presented 
graphically as a percentage of total EGF-TxR puncta counted. 35 cells in 3 
independent experiments were analysed and data is shown as mean ± SEM. **P<0.01 
























Fig. 4.8. Manipulation of Rab31 levels affects rate of degradation of ligand-bound 
EGFR  
HeLa cells overexpressing Rab31 (Rab31 OE) and those that were transfected with 
Scrambled (Scr) or Rab31 siRNA were pulsed with 0.5 μg/mL EGF.  
A) At the various time points indicated, lysates were harvested and probed by Western 
blot for total EGFR and γ-tubulin. Shown is a representative set of data from 6 
independent experiments.  
B) Levels of EGFR were normalised against γ-tubulin and plotted graphically as a 
percentage of EGFR at 0 min after pulse. Data represents mean ± SEM of 6 
independent experiments.  *P<0.05 between Scr and Rab31 siRNA, or Scr and Rab31 














To verify that Rab31 is indeed the critical factor depleted in the depletion 
experiments, we attempted to rescue Rab31-silenced cells by transfecting the cells 
with Myc-tagged mouse Rab31 (Myc-mRab31), which differs in sequence from 
human Rab31 targeted by our siRNA. Overexpression of silencing-resistant Myc-
mRab31 could indeed rescue the ligand-bound EGFR trafficking defect caused by 
loss of Rab31. After a 30 min chase with EGF-TxR, cells in which the rescue of 
Rab31 knockdown phenotype had occurred (as evidenced by the expression of Myc-
tagged mRab31) displayed larger EGF-TxR puncta compared to cells in the same 
population that did not express Myc-mRab31 (Fig. 4.9A). Quantification of this 
phenomenon showed that there was significantly larger percentage of puncta that 
are >0.25 μm in cells overexpressing Myc-mRab31, compared to cells without 
overexpression or cells transfected with the vector control (Fig. 4.9B). We also 
quantified the percentage of EGF-TxR puncta that were positive for CD63 
(arrowheads), after a 30 min chase (Fig. 4.10). In cells with Myc-mRab31 
overexpression, the percentage of EGF-TxR and CD63 colocalisation was 
significantly increased compared to cells in the same population with no Myc-
mRab31 expression. The percentage was also significantly higher compared to cells 
transfected with the empty vector. Taken together, our results suggest that Rab31 





Fig. 4.9. Rescue of Rab31 depletion restores the endocytic trafficking defect of ligand-
bound EGFR as quantified by puncta size  
A431 cells were transfected with Scrambled (Scr) or Rab31 siRNA for 48 h before 
subsequent transfection with siRNA silencing-resistant Myc-tagged mouse Rab31 
(Myc-mRab31) or empty Myc vector (Myc VC). Cells were pulsed 24 h later with 0.5 
μg/mL EGF-TxR followed by chase and fixation at various time points. 
A) Immunofluorescence analysis for EGF-TxR (red) and Myc-mRab31 (green). 
Asterisks indicate Myc-mRab31 overexpressing cells with larger EGF-TxR puncta 
compared to non-overexpressing cells.  Scale bar = 20 μm.  
B) Sizes of EGF-TxR puncta in cells with (Rescue), and without Myc-mRab31 
expression (No rescue), and cells transfected with empty Myc vector (Myc VC) after 
Rab31 siRNA treatment were quantified using ImageJ, and the size distribution is 
represented graphically as a bar chart. 15 cells in 3 independent experiments were 









Fig. 4.10. Rescue of Rab31 depletion restores the endocytic trafficking defect of 
ligand-bound EGFR as quantified by colocalisation with CD63  
A) The effect of depleting Rab31 and subsequent rescue was determined by assessing 
the amount of EGF-TxR (red) that have entered the CD63 (green)-containing late 
endosome. Box A encloses the central region of a representative cell with Myc-
mRab31 expression (pseudo-coloured white) while Box B encloses a representative 
cell without. Lower panel shows individual and merged fluorescence signals of the 
boxed areas, magnified 2x. Arrowheads indicate some EGF-TxR puncta (red) that are 
also positive for CD63 (green). Scale bar = 20 μm. 
B) The percentage of EGF-TxR puncta that are positive for CD63 in cells with 
(Rescue), or without  Myc-mRab31 expression (No rescue) and cells transfected with 
empty Myc vector (Myc VC) after Rab31 siRNA treatment, were quantified and 
presented graphically as a percentage of total EGF-TxR puncta counted. 29 cells in 3 
independent experiments were analysed and data is shown as mean ± SEM. **P<0.01 






















Rab31 associates with an EGFR-trafficking complex 
We sought to determine how Rab31 could influence the trafficking of EGFR. 
We found that Rab31 associated with EGFR in a GTP-dependent manner by co-
immunoprecipitation with anti-Rab31 antibodies (Fig. 4.11A). Rab5, in comparison, 
co-immunoprecipitated lesser amounts EGFR. Similarly, we were able to affinity 
pulldown EGFR using glutathione S-transferase (GST)-Rab31, but not GST, in the 
presence of a non-hydrolysable GTP analogue GTPγS in both A431 and HeLa cells 
(Fig. 4.11B, C). In contrast, little or no EGFR was pulled down using GST-tagged 
Rab31 S19N, a dominant negative, GDP-locked mutant of Rab31 (Fig. 4.11D), 
suggesting that Rab31 must be in its active, GTP-bound form to associate with EGFR.  
We looked closer at how Rab31 might be associated with EGFR during its 
endocytic traffic. Using immunofluorescence analysis of A431 cells stably transfected 
with EGFP-Rab31 and pulse-chased with EGF-TxR, we observed that a portion of the 
EGFP-Rab31 signal associates with the EGF-positive punctate structures indicative of 
endosomes bearing the ligand-bound EGFR. This association was particularly evident 
after a 30 min chase (Fig. 4.12A, B), a period when ligand-bound EGFR is likely to 
be transiting between early and late endosomes (Liu et al., 2009). We quantified the 
percentage of EGF-TxR puncta that are also immunopositive for Rab31, and found 
that the percentage increases upon EGF pulse and is statistically significant at 30 min. 
This suggests that a portion of Rab31 may become localised in the endosomal 
membrane rather than the TGN, and may associate as part of a trafficking complex 
with ligand-bound EGFR. We likewise observed a percentage of colocalisation 
between Rab31 and EGF in an orthogonal projection of HeLa cells transfected with 
mCherry-Rab31 and pulse-chased with EGF-FITC (Fig. 4.12C), suggesting that this 




stably expressing EGFP-Rab31 and pulsed with EGF-TxR also showed a gradual 
increase in colocalisation between Rab31 and EGF (Fig. 4.13). 
 
Fig. 4.11. Rab31 associates with EGFR by affinity assays  
A) EGFR was co-immunoprecipitated with Rab31 or Rab5 antibody respectively, 
using 1 mg lysates from cells transfected with vector alone (Vector ctrl)  and Rab31 
(Rab31 OE) respectively, with or without GTPγS loading.  
B) 1 mg of A431 cell lysate with and without GTPγS were incubated with 20 μg GST 
or GST-Rab31 and glutathione beads, and the ability of the GST fusion proteins to 
pulldown EGFR was analysed by Western blot. The GST fusion proteins were 
visualised with Ponceau S stain. 
C) 1 mg of HeLa A431 cell lysate with and without GTPγS were incubated with 20 
μg GST or GST-Rab31 and glutathione beads, and the ability of the GST fusion 
proteins to pulldown EGFR was analysed by Western blot. The GST fusion proteins 
were visualised with Ponceau S stain.  
D)  1 mg of A431 cell lysate with and without GTPγS was incubated with 20 μg GST-
Rab31 or GST-Rab31 S19N and glutathione beads, and the ability of the GST fusion 
proteins to pulldown EGFR was analysed by Western blot. The GST proteins were 




























Fig. 4.12. Rab31 associates with EGFR 30 min after EGF pulse  
A) A431 cells stably transfected with EGFP-Rab31 were pulsed with 0.5 μg/mL EGF-
TxR, fixed after 30 min and analysed for colocalisation between EGFP-Rab31 (green) 
and EGF-TxR (red). The lower panel are the boxed areas in the upper panel, enlarged 
2x. Arrows indicate structures positive for both EGFP-Rab31 and EGF-TxR. Scale 
bar = 20 μm.  
B) Percentage of EGF-TxR positive puncta that are also positive for EGFP-Rab31 was 
quantified from cells fixed after 0, 10 and 30 min chase, and graphically represented 
as a percentage of total EGF-TxR puncta counted. 34 cells in 3 independent 
experiments were analysed and data is shown as mean ± SEM. **P<0.01 by Student’s 
t-test.  
C) HeLa cells were pulsed with 0.5 μg/mL EGF-FITC, fixed after 30 min and 
analysed for colocalisation between mcherry-Rab31 (red) and EGF-FITC (green) in 
an orthogonal projection of z-stacked images. Arrows indicate structures positive for 






Fig. 4.13. Rab31 gradually increases in association with EGFR after EGF pulse as 
seen by live imaging  
A431 cells stably transfected with EGFP-Rab31 were pulsed with 0.5 μg/mL EGF-
TxR and imaged at various time points. There is partial colocalisation between EGFP-





That Rab31 may indeed be part of an EGFR-containing trafficking complex 
was further supported by a glycerol gradient sedimentation analysis of proteins from 
Rab31-expressing A431 lysate. Like the early endosome-residing Rab5, Rab31 was 
found mainly in the lighter fractions. However, in the presence of GTPγS and after a 
pulse-chase with EGF, Rab31 was seen in higher molecular weight fractions, 
including those where thyroglobulin (a 660kDa dimeric protein) was co-sedimented 
(Fig. 4.14A). There was, however, no discernible extension of Rab5 to the high 
molecular weight fractions, even when the blot was overexposed, suggesting that the 
effect of entering higher molecular weight fractions with GTPγS is specific to Rab31. 
Interestingly, we observed that the spreading of Rab31 to the heavier fractions 
occurred at later and not earlier time points of a pulse-chase with EGF, i.e. at 30 and 
60 min (Fig. 4.14B). Taken together, the results give some indication that after EGF 
stimulation, Rab31 becomes associated with a high molecular weight complex that 
likely contains EGFR, during the time when ligand-bound EGFR is likely to be 





Fig. 4.14. Rab31 associates with a high molecular weight complex 
A) 2 mg of A431 Rab31 OE lysates with and without GTPγS loading was resolved by 
glycerol gradient sedimentation. Fractions were collected, TCA-precipitated and 
analysed by Western blot for Rab31, EEA1, EGFR, and Rab5. The membrane blot for 
Rab5 was also overexposed.  
B) Lower panel: A431 Rab31 OE cells were pulsed with 0.5 μg/mL EGF and 
harvested at various time points. 2 mg of lysates were separated by glycerol gradient 
sedimentation.  
The position in the gradient that contains the molecular size markers bovine serum 









Rab31-mediated EGFR trafficking occurs downstream of Rab5 
Rab5 has been suggested to play a role in both the early and later stages of 
EGFR trafficking, including internalisation and entry into the early endosome, as well 
as the transition between the early to late endosome (Barbieri et al., 2000; Dinneen and 
Ceresa, 2004), with Rab5a being the main isoform involved (Chen et al., 2009). Our 
results thus far are consistent with Rab31 playing a role in the later stages of EGFR 
trafficking, probably during transit into late endosomes, by associating with a high 
molecular weight complex that that likely contains EGFR. We thus sought to 
determine if there was any interplay between Rab5 and Rab31 in EGFR endocytic 
transport. We transfected cells with mCherry-Rab5a or Rab31 and quantified the 
percentage of EGF-FITC puncta positive for Rab5 and Rab31 at various time points 
post-pulse. We found that Rab5 remains associated with EGF puncta up to 60 min 
post-pulse, with a slight decrease between 10 and 30 min (Fig. 4.15A). In contrast, we 
found that the association between Rab31 and EGF only increased significantly at 30 
min. Together, the results suggest that while Rab5 appears to associate with both 
EGFR-carrying early and late endosomes, and may play a role in both early and later 
stages of EGFR trafficking, Rab31 is more likely to be involved only at the early to 
late endosome transit stage.  
The loss of Rab31 caused a more significant inhibition of colocalisation 
between ligand-bound EGFR and CD63 than a loss of Rab5, suggesting that Rab5 
only plays a partial role in this trafficking step (Fig. 4.15B). A double Rab5a and 
Rab31 depletion further reduced the percentage of colocalisation. This suggests that 
while Rab5 may play a role in both the early and later stages of EGFR trafficking, 
Rab31 is more essential in the later trafficking of ligand-bound EGFR between early 




positive for Rab31, which may simply reflect the transient nature of Rab31’s 
association with EGFR-containing membrane structures.  
 
 
Fig. 4.15. Rab31 appears to act downstream of Rab5 in EGFR trafficking  
A) A431 cells were transfected with either mCherry-Rab5a or mCherry-Rab31. Cells 
were pulsed with 0.5 μg/mL EGF-FITC and fixed at the various time points indicated 
for immunofluorescence analysis. Percentage of EGF-FITC positive puncta that are 
positive for either Rab5 or Rab31 was quantified from cells fixed after 0, 10, 30 and 
60 min chase, and presented graphically as a percentage of total EGF-FITC puncta 
counted. 29 cells in 3 independent experiments were analysed and data is shown as 
mean ± SEM.   
B) A431 cells were transfected with scrambled (Scr), Rab5a or Rab31 siRNA as 
indicated and subsequent analyses were performed after 48 h. Left panel: The extent 
of knockdown was assessed by RT-PCR. Rab5a was depleted by 70% and Rab31 by 
75%. Right panel: Cells were pulsed with 0.5 μg/mL EGF-TxR and fixed at 30 min. 
Cells were immunostained for CD63 and the percentages of EGF-TxR puncta that 
were also positive for CD63 were quantified and presented graphically as a 
percentage of total EGF-TxR puncta counted. 27 cells in 3 independent experiments 






































4.3 Results: Rab31 in recycling of EGFR  
Role of Rab31 in EGFR trafficking is focussed on the degradative, not recycling, 
pathway  
 Up to this point, we have focussed on the role of Rab31 in the degradative 
trafficking pathway of ligand-bound EGFR. Thus far, our data suggests that Rab31 is 
involved in a later step in EGFR trafficking, after Rab5, and involves the movement 
of ligand-bound EGFR from early to late endosomes. Notably, though, upon 
stimulation by EGF, there is also a fraction of the ligand-bound EGFR that is recycled 
back to the cell surface (Masui et al., 1993; Tong et al., 2013). We investigated how 
Rab31 might play a role in this process, or if its effect is limited specifically to the 
degradative pathway.  
 After a pulse with EGF-FITC, we determined the rate of recycling of EGFR in 
cells as reflected by the percentage of EGF/EGFR puncta colocalising with Rab11, a 
marker for recycling endosomes. As Rab11 was present at higher levels in HeLa cells 
compared to A431 (hardly detectable by immunofluorescence), we used HeLa cells 
for this set of experiments. Depletion of Rab31 significantly increased the percentage 
of EGF-FITC puncta colocalising with Rab11 at 10 and 20 min, compared to controls 
(Fig. 4.16A), while overexpression of Rab31 decreased the percentage (Fig. 4.16B). 
Our results suggest that by enhancing the movement of ligand-bound EGFR from 
early to late endosomes, Rab31 may channel more ligand-bound EGFR to the 
degradative pathway, thus indirectly reducing the percentage of EGFR recycled to the 










































Fig. 4.16. Rab31 indirectly impacts the recycling itinerary of ligand-bound EGFR  
A) HeLa cells were transfected with either Scrambled (Scr) or Rab31 siRNA and 
subsequent assays were performed after 48 h. Cells were pulsed with 0.25 μg/mL 
EGF-FITC (green), fixed at 20 min, and analysed by colabelling for Rab11 (red). 
Upper panel: Arrows indicate some structures positive for both EGF-FITC and 
Rab11. Scale bar = 20 μm. Lower panel: Percentage of EGF-FITC puncta that are 
also positive for Rab11 was quantified from cells fixed after 10 and 20 min chase and 
presented graphically as a percentage of total EGF-FITC puncta counted. 27 cells in 3 
independent experiments were analysed and data is shown as mean ± SEM. **P<0.01 
and ***P<0.001 by Student’s t-test.  
B) HeLa cells were transfected with Rab31 (blue), pulsed with 0.25 μg/mL EGF-FITC 
(green) and fixed at 20 min for analysis by co-immunostaining for Rab11 (red). Upper 
panel: Arrows indicate some structures positive for both EGF-FITC and Rab11. Scale 
bar = 20 μm. Lower panel: Percentage of EGF-FITC puncta that are positive for 
Rab11 was quantified from cells fixed after 10 and 20 min chase and presented 
graphically as a percentage of total EGF-FITC puncta counted. 27 cells in 3 
independent experiments were analysed and data is shown as mean ± SEM. **P<0.01 
by Student’s t-test. 
 
 
4.4 Chapter Discussion: Rab31 plays a role in early-to-late endosome trafficking 
of ligand-bound EGFR through a trafficking complex  
We have expanded our previous understanding of the role of Rab31 in EGFR 
trafficking by showing that Rab31 is likely to participate at the stage when ligand-
bound EGFR traffics from early to late endosome, by forming a trafficking complex 
with EGFR. Currently, how Rab31 factors in the EGFR trafficking process in 
comparison to other Rabs involved has not yet been fully defined. Our results point to 
the possibility that Rab31 acts downstream of the initial internalisation of EGFR that 
is coordinated by Rab5.  It is pertinent to note here that Rab5, in some studies, has 
also been shown to be involved in the trafficking step between early and late 
endosome. It is not entirely clear to what extent Rab5 is essential for this step, but 
evidence suggests that loss of Rab5 does not completely block the trafficking (Chen et 
al., 2009; Dinneen and Ceresa, 2004). Moreover, here we have shown that Rab31 




compared to Rab5 depletion. At the very least, Rab31 can be said to function 
alongside Rab5 in the trafficking of ligand-bound EGFR.   
There are many instances in literature of the interplay between various Rabs in 
the ordering of transport steps. For example, Rab5 and Rab7 have been shown to 
coordinate the maturation of endosomes via a process termed Rab conversion, when 
the preceding Rab engages various proteins that recruit the subsequent Rab (Rink et al., 
2005). How and when the various Rabs coordinate EGFR-related traffic remains to be 
fully elucidated. Renzis et al. described the divalent effector Rabenosyn5, which binds 
both Rab5 and Rab4 simultaneously, enabling Rab5 and Rab4 membranes to interact, 
thus allowing the transition between early endosomes and fast recycling endosomes 
(De Renzis et al., 2002). It is thus likely that other interacting proteins facilitate the 
Rab31-mediated transition of ligand-bound EGFR between the early and late 
endosome. Having seen that Rab31 is part of a trafficking complex that is likely to 
include EGFR, we thus sought to determine which other interacting partners of Rab31 






5. The role of Rab31-interacting proteins in Rab31-mediated EGFR trafficking 
5.1 Chapter Introduction: Potential Rab31-interacting proteins in an EGFR-
trafficking complex 
As discussed in Section 4.4, Rab31 is part of a trafficking complex that is 
likely to include EGFR, and plays a role in the early-to-late endosome transition. At 
the same time, other interacting proteins of Rab31 are likely to be part of this 
trafficking complex, and may mediate the transition between early and late endosome. 
EEA1, as a common effector for both Rab5 and Rab31, might also fulfil this role, as it 
has two Rab binding domains; Rab5 has greater affinity for the N-terminal domain, 
whereas Rab31 has equal affinity for both (Lodhi et al., 2007). Our glycerol gradient 
sedimentation results suggest that the trafficking complex is of high molecular weight 
and likely includes more than just EGFR. In the glycerol gradient sedimentation of the 
A431 lysate, we observed that along with Rab31, EEA1’s presence also appeared to 
be extended to the higher molecular weight fractions upon EGF pulse (Fig. 4.13). We 
therefore sought to take a closer look at the role of EEA1 in Rab31-mediated EGFR 
trafficking. 
We also chose to explore the role of GAPex5 in Rab31-mediated EGFR 
trafficking. GAPex5 contains a Ras-GAP domain and also a VPS9 GEF domain, and 
has been identified to bind to EGFR through Cbl, an E3 ubiquitin ligase, upon 
receptor dimerisation (Su et al., 2007). We have shown in Section 3.3 that depletion of 
GAPex5 impacts the subcellular localisation of Rab31. We therefore sought to 
investigate if this also had subsequent effects on the trafficking of ligand-bound 




5.2 Results: Role of EEA1 in Rab31-mediated EGFR trafficking 
EEA1 is part of the Rab31-EGFR trafficking complex and plays a role in Rab31-
EGFR association 
Using immunofluorescence analysis of A431 cells stably expressing EGFP-
Rab31, we observed that after a pulse-chase with EGF-TxR, a portion of the EEA1 
puncta colocalised with Rab31, together with EGF-TxR (Fig. 5.1A). This percentage 
increased gradually and was significant after a 30 min chase with EGF (Fig. 5.1B). 
This mirrors the colocalisation data between Rab31 and EGFR, and suggests that 
EEA1 may be associated together with Rab31 and EGFR, likely in high molecular 
weight trafficking complexes.   
We further probed the role of EEA1 in the Rab31-EGFR association. With a 
loss of EEA1, GST-Rab31 was unable to pulldown EGFR, even with the presence of 
GTPγS (Fig. 5.2A). This suggests that EEA1 must be present for the interaction 
between Rab31 and EGFR to occur. (We should note that while EEA1 interaction 
itself was not detected here, we were able to detect GST-Rab31 pulldown of EEA1 if 
cells were first pulsed with EGF before harvesting of cell lysate for the assay (Fig. 
5.2B)). Furthermore, after a 30 min pulse-chase with EGF-TxR, there was a 
delocalisation between EGFP-Rab31 and EGF-TxR when EEA1 was silenced, 
compared to cells in the control population (Fig. 5.3). This supports our postulation 






Fig. 5.1. EEA1 colocalises with Rab31 and EGFR  
A)A431 cells stably expressing EGFP-Rab31 (green) were pulsed with 0.5 μg/mL 
EGF-TxR (red), fixed at various time points, and co-labelled using EEA1 antibodies 
(pseudo-coloured blue). Arrows indicate some structures positive for EGFP-Rab31, 
EGF-TxR and EEA1. Scale bar = 20 μm.  
B) Percentage of EEA1 puncta that are positive for Rab31 was quantified from cells 
fixed after 0, 10 and 30 min chase and presented graphically as a percentage of total 
EGF-TxR puncta counted. 33 cells in 3 independent experiments were analysed and 






















Fig. 5.2. EEA1 associates with Rab31 and EGFR  
A) A431 cells were transfected with Scrambled (Scr) or EEA1 siRNA. 1 mg lysates 
with and without GTPγS were incubated with 20 μg GST-Rab31 and glutathione 
beads. The ability of GST-Rab31 to affinity pulldown EGFR was analysed by 
Western blot. Ponceau S staining of the GST proteins used is shown.  
B) Cells were pulsed with 0.5 μg/mL EGF before harvesting after a 30 min chase. 1 
mg lysates with and without GTPγS were incubated with 20 μg GST-Rab31 and 
glutathione beads. Ability of GST-Rab31 to affinity pulldown EGFR and EEA1 was 






























Fig. 5.3. Depletion of EEA1 results in delocalisation between Rab31 and EGFR 
A431 cells stably expressing EGFP-Rab31 (green) were transfected with Scr or EEA1 
siRNA. Cells were pulsed 48 h later with 0.5 μg/mL EGF-TxR (red), fixed after 30 
min, and co-labelled for EEA1 (pseudo-coloured blue).  
A) Knockdown of EEA1 was assessed by immunofluorescence (left) and Western blot 
(right). EEA1 was depleted by 80%. Arrowheads also indicate points of colocalisation 
between EGFP-Rab31, EGF-TxR and EEA1 puncta. Scale = 20 μm.  
B) Orthogonal projection of the 3D stacked confocal images shown in (A). In cells 
transfected with the scrambled siRNA there is colocalisation between EGFP-Rab31 
(green) and EGF-TxR (red) (arrows). In cells with EEA1 knockdown, EGFP-Rab31 
and EGF-TxR appeared delocalised (arrowheads).  
C) Percentage of EGF-TxR positive puncta that are also positive for EGFP-Rab31 
was quantified from Scr and EEA1 siRNA transfected cells fixed after 0, 10 and 30 
min chase, and graphically represented as a percentage of total EGF-TxR puncta 
counted. 29 cells in 3 independent experiments were analysed and data is shown as 
mean ± SEM. **P<0.01 by Student’s t-test. 
 
We next looked at how the loss of EEA1 might affect the Rab31-mediated 
enhancement of endocytic trafficking of ligand-bound EGFR. When EEA1 was 
silenced, there appeared to be little difference in the size of EGF puncta between cells 
overexpressing Rab31 (asterisks) and non-overexpressing cells (Fig. 5.4), unlike cells 
in the control population. Quantification of this phenomenon showed that there was 
significantly lower percentage of puncta <0.05 μm in cells overexpressing Rab31 in 
the Scr siRNA transfected population, whereas this difference was lost in the EEA1-
silenced population. We also quantified the percentage of EGF-TxR puncta that were 
positive for CD63 (Fig. 5.5), and found that in the control population, there was a 
significantly higher percentage of colocalisation in cells with Rab31 overexpression 
(Box A), compared to cells without overexpression (Box B). In contrast, in EEA1-
silenced cells, there was no significant difference between Rab31-overexpressing and 
non-overexpressing cells. This suggests that the Rab31-mediated effect on EGFR 
trafficking to the CD63 late endosome compartment is abrogated with a loss of EEA1. 
Overall, our results suggest that Rab31 associates with ligand-bound EGFR and 




Fig. 5.4. EEA1 is important for the Rab31-mediated enhancement of ligand-bound 
EGFR endocytic trafficking 
A431 cells stably expressing EGFP-Rab31 were transfected with Scr or EEA1 siRNA 
and analysed after 48 h.  
A) The levels of EEA1 and EGFR were analysed by Western blot. EEA1 was depleted 
by 80%. Cells were pulsed with 0.5 μg/mL EGF-TxR (red), and fixed at 30 min for 
comparison of the puncta sizes between cells overexpressing EGFP-Rab31 (green, 
asterisks)  and non-overexpressing cells in the same populations. Scale bar = 20 μm.  
B) Sizes of EGF-TxR puncta in Rab31 overexpressing (OE) and non-overexpressing 
cells from the Scrambled (upper graph) or EEA1 siRNA-treated populations (lower 
graph) were quantified using ImageJ, and the size distribution is represented 
graphically as a bar chart. 19 cells in 3 independent experiments were analysed and 



























Fig. 5.5. Depletion of EEA1 reduces entry of ligand-bound EGFR into late endosome  
A) Scr and EEA1 siRNA treated cells were immunostained for CD63 (pseudo-
coloured green), along with EGF-TxR (red) and EGFP-Rab31 (pseudo-coloured 
white). The lower panel shows individual and merged fluorescence signals of the 
boxed areas, magnified 2x. Box A represents cell with Rab31 overexpression while 
Box B represents cells with no overexpression. Arrows indicate some structures 
positive for both EGF-TxR and CD63. Scale bar = 20 μm.  
B) The percentage of EGF-TxR puncta that are positive for CD63 were quantified and 
graphically represented as a percentage of total EGF-TxR puncta counted. 36 cells in 
3 independent experiments were analysed and data is shown as mean ± SEM. 
**P<0.01 by Student’s t-test. 
 
 
5.3 Results: Role of GAPex5 in Rab31-mediated EGFR trafficking 
The Rab31 GEF GAPex5, but not RIN3, plays a role in the Rab31-EGFR trafficking 
complex 
 GAPex5 is a guanine nucleotide exchange factor (GEF) for Rab31, and thus 
acts to activate Rab31 by enhancing the exchange of GDP for GTP. It has also been 
shown to be involved in the early steps of ligand-bound EGFR internalisation by 
interacting with Cbl, which itself binds to EGFR upon stimulation with the ligand (Su 
et al., 2007). As such, GAPex5 stands as a good candidate for a possible mediator of 
the formation of the Rab31-EGFR trafficking complex.  
In our initial studies with depletion of GAPex5 in Rab31-overexpressing A431 
cells, we observed that loss of GAPex5 resulted in a distinct dispersal of Rab31 from 
the TGN, as seen by a delocalisation with the trans-Golgi marker TGN46 (Fig. 3.4). 
This effect was specific to GAPex5, as depletion of another GEF of Rab31, RIN3 
(Kajiho et al., 2011), did not bring about a similar effect in A431 cells. The dispersal of 
Rab31 from the TGN did not result in its corresponding accumulation in other 





 We thus looked at how GAPex5 depletion would affect the Rab31-EGFR 
interaction. Loss of GAPex5 resulted in a reduced pulldown of EEA1 and EGFR by 
GST-Rab31, even in the presence of GTPγS (Fig. 5.6A, B). Interestingly, as with the 
dispersal of Rab31 from the TGN, this effect was specific to GAPex5, as RIN3 
depletion did not produce the same result (Fig. 5.6C). This suggests that reduced 
Rab31-EGFR interaction seen with a GAPex5 knockdown was not due to reduction in 
Rab31 activation resulting from a general loss of GEF activity, but was rather a 
GAPex5 specific effect.  
 
Fig. 5.6. Depletion of GAPex5 abrogates Rab31-EGFR association  
A) A431 cells were transfected with GAPex5 siRNA and harvested 48 h later. The 
extent of GAPex5 knockdown and the levels of EGFR were assessed by Western blot. 
GAPex5 was depleted by 80%.  
B) GST-Rab31 affinity pulldown assay was performed with the harvested lysates. 
Cells were pulsed with 0.5 μg/mL EGF before harvesting after a 30 min chase. 1 mg 
lysates with and without GTPγS were incubated with 20 μg GST-Rab31 and 
glutathione beads. Ability of GST-Rab31 to affinity pulldown EGFR and EEA1 was 
analysed by Western blot. Ponceau S staining of the GST proteins used is shown.  
C) 1 mg of A431 cell lysate harvested 48 h after transfection with relevant siRNA 
were incubated with 20 μg GST or GST-Rab31 and glutathione beads, in the presence 
of GTPγS, and the ability of the fusion proteins to pulldown EGFR was analysed by 







As with EEA1 depletion, the loss of GAPex5 abrogated Rab31-mediated 
enhancement of ligand-bound EGFR trafficking. In the population of control cells, 
those overexpressing EGFP-Rab31 (asterisks) had larger EGF-TxR puncta 30 min 
post-pulse, compared to those without overexpression. This difference was not 
observed in the population of GAPex5-silenced cells (Fig. 5.7). Quantification of this 
phenomenon showed that there was significantly higher percentage of puncta >0.25 
μm in cells overexpressing Rab31 in the Scr siRNA transfected population, whereas 
this difference was lost in cells in the GAPex5-silenced population. Also, in the 
control population, there was a significantly higher percentage of colocalisation 
between EGF-TxR and CD63 in cells with Rab31 overexpression (Box A), compared 
to cells without overexpression (Box B) (Fig. 5.8). In contrast, in the GAPex5-
silenced population, there was no significant difference between Rab31-
overexpressing and non-overexpressing cells. Together, the results suggest that the 
Rab31 GEF GAPex5, but not RIN3, may have a specific role in Rab31-EGFR 
trafficking, in bringing together the interaction between Rab31, EGFR and EEA1 in 





Fig. 5.7. GAPex5 is important for the Rab31-mediated enhancement of ligand-bound 
EGFR endocytic trafficking  
A) A431 cells stably expressing EGFP-Rab31 (green) were transfected with 
Scrambled (Scr) or GAPex5 siRNA. Cells were pulsed with 0.5 μg/mL EGF-TxR and 
fixed at 30 min for analysis of the size of EGF-TxR (red) puncta in cells that do 
(asterisks) or do not overexpress EGFP-Rab31. Scale bar = 20 μm.  
B) Sizes of EGF-TxR puncta in Rab31 overexpressing (OE) and non-overexpressing 
cells from the Scr (left graph) or GAPEx5 siRNA-treated population (right graph) 
were quantified using ImageJ, and the size distribution is represented graphically as a 
bar chart. 21 cells in 3 independent experiments were analysed and data is shown as 



























Fig. 5.8. Depletion of GAPex5 hinders entry of ligand-bound EGFR into late 
endosome 
A) Scr and GAPex5 siRNA treated cells were immunostained for CD63 (pseudo-
coloured green), along with EGF-TxR (red) and EGFP-Rab31 (pseudo-coloured 
white). The lower panel shows individual and merged fluorescence signals of the 
boxed areas, magnified 2x. Box A encloses the central area of cells with Rab31 
overexpression while Box B encloses central areas of cells with no Rab31 
overexpression. Arrows indicate some structures positive for both EGF-TxR and 
CD63. Scale bar = 20 μm.  
B) The percentage of EGF-TxR puncta that are also positive for CD63 were 
quantified and are graphically presented as a percentage of total EGF-TxR puncta 
counted. 41 cells in 3 independent experiments were analysed and data is shown as 
mean ± SEM. **P<0.01 by Student’s t-test.  
 
 
5.4 Results: RIN3 mediates a separate trafficking role of Rab31 
In our investigation into the effect of depletion of RIN3, we observed that 
there was no significant effect on trafficking of EGFR. However, we observed a 
separate phenomenon affecting the localisation of M6PR.  
The cation dependent and cation independent mannose 6-phosphate receptors 
(M6PR) are transmembrane receptors which recognise the mannose 6-phosphate post-
translational modification on newly synthesised proteins such as acid hydrolases at 
the TGN. These serve to transport the acid hydrolases to the endosomal network. In 
the acidified environment, M6PRs release their cargo and are recycled to the TGN, 
while the cargo is subsequently trafficked to lysosomes, where they serve their 
function. M6PR thus cycles between the TGN and the endosomal network (Damen et 
al., 2006).   
The loss of RIN3, in cells overexpressing Rab31, resulted in a dispersed 
localisation of M6PR. This was not seen in a knockdown of GAPex5 (Fig. 5.9A, B). 
The overall protein levels of M6PR did not appear severely affected (Fig. 5.9C). We 
also looked at the effect on another late endosomal marker, CD63, and saw no effect, 




indicated that the effect was not a general disruption of endocytic trafficking 
pathways or markers. Also, the effect of RIN3 depletion on M6PR was not merely 
due to the loss of a functional active Rab31, since the phenomenon was only seen in 
cells with Rab31 overexpression. Moreover, depletion of Rab31 did not recapitulate 
the phenomenon that we observed (Fig. 5.11A). Also, the effect was only observed in 
cells overexpressing Rab31, but not another Rab from the Rab5 subfamily, Rab22, 
which is implicated in early endosomal trafficking (Fig. 5.11B). Taken together, our 
results suggest that the loss of RIN3 affects the localisation of M6PR specifically, in 
cells with high levels of Rab31. 
Our results suggest that Rab31 may play a role in multiple trafficking events 
within the cell. This, in turn, is likely to be determined in part by the localisation and 




Fig. 5.9. Depletion of RIN3 results in disruption to the localisation of M6PR  
A431 cells stably expressing EGFP-Rab31 (green) were transfected with Scr, 
GAPex5 or RIN3 siRNA and analysed after 48 h.   
A) Cells were immunostained for M6PR (red). Asterisks indicate cells with Rab31 
overexpression and dispersed M6PR staining. Scale bar = 20 μm.  
B) Number of M6PR-labelled particles was quantified by ImageJ. 43 cells in 3 
independent experiments were analysed and data is shown as mean ± SEM. **P<0.01 
by Student’s t-test. 
C) Cell lysate was also harvested and analysed by Western blot for the proteins 
indicated. GAPex5 and RIN3 were depleted by 80%.    
 
A) 





Fig. 5.10. Depletion of RIN3 does not affect CD63 or EEA1 localisation  
A431 cells stably expressing EGFP-Rab31 (green) were transfected with Scr, 
GAPex5 or RIN3 siRNA and analysed after 48 h.   
A) Cells were immunostained for CD63 (red).  
B) Cells were immunostained for EEA1 (red).  







Fig. 5.11. Effect of RIN3 depletion on M6PR is specific to cells with Rab31 
overexpression 
A) A431 cells were transfected with Scr or Rab31 siRNA and analysed after 48 h. 
Cells were fixed and immunostained for TGN46 (green) and M6PR (red). 
B) A431 cells were transfected with Rab22 expression vector and RIN3 siRNA and 
analysed after 48 h. Cells were fixed and immunostained for Rab22 (green, asterisks) 
and M6PR (red). 











5.5 Chapter Discussion: Interacting proteins mediate different roles of Rab31  
Role of EEA1 in Rab31-EGFR trafficking complex 
We have shown in Section 5.2 that EEA1 colocalised with Rab31 puncta upon 
EGF stimulation. When EEA1 expression was silenced, the interaction between 
Rab31 and EGFR was lost, and the effect of Rab31 overexpression on ligand-bound 
EGFR trafficking was also attenuated. We thus postulate that Rab31 might be 
mediating its effect on trafficking of EGFR through an EEA1-containing trafficking 
complex.  
To date, evidence for the role of EEA1 in endocytosis of EGFR has been 
varied, with some evidence pointing towards EEA1 being dispensable, at least in the 
early step of clathrin-mediated internalisation of EGFR from the cell surface (Chen 
and Wang, 2001; Huang et al., 2004). Likewise, in our hands, depletion of EEA1 did not 
abrogate the initial internalisation of EGFR. What our results do suggest that EEA1 is 
directly involved in the interaction between Rab31 and EGFR, and is important for 
Rab31-regulated trafficking of EGFR between early and late endosomes. It is 
tantalizing to speculate that Rab31 might perhaps be recruited to the EGFR trafficking 
complex subsequent to the involvement of Rab5, which may be responsible for first 
engaging EEA1 onto EGFR-carrying endosomes. 
 
Role of a GEF in Rab31/EEA1-mediated EGFR trafficking complex 
We have previously shown that loss of GAPex5 phenocopied Rab31 depletion 
(Ng et al., 2009). Here, we have further shown that overexpression of Rab31 is unable 
to rescue a loss of GAPex5. One reason for this is likely to be the reduced activation 




RIN3, another GEF for Rab31, does not have the same effect, suggesting that the role 
of GAPex5 in Rab31-mediated EGFR trafficking may extend beyond its GEF activity. 
As GAPex5 has been shown to bind EGFR via Cbl, a second plausible explanation is 
that its presence in the EGFR-trafficking complex is essential for Rab31 function. It is 
likely that the presence of GAPex5 in the EGFR-containing complex is responsible 
for recruiting Rab31 onto EGFR-carrying endosomes. Once there, activated Rab31 
can further engage its effector EEA1. We have not, however, been able at present to 
discern an interaction between Rab31 and other components of EGFR signalling such 
as Cbl (data not shown). Interestingly, we observed that depletion of GAPex5 resulted 
in dispersal of Rab31 from the TGN. This dispersal may impact the role of Rab31 in 
EGFR trafficking as well, possibly by disrupting the cycling of Rab31 between the 
TGN and the endocytic pathway (Rodriguez-Gabin et al., 2001).  
GAPex5 is believed to be a GEF for Rab5 as well. Although it may seem 
somewhat counter-intuitive for a GEF to act as an activator for two Rab GTPases that 
we believe may act consecutively, examples can be found in other instances. For 
example, by engaging different subunits, the GEF TRAPP complex switches from 
acting on the cis-Golgi Rab Ypt1 (mediating ER-Golgi transport), to the trans-Golgi 
Rab Ypt32 (mediating exit from the Golgi) (Morozova et al., 2006). Alternatively, it is 
also possible that another GEF may be more critical for the Rab5-dependent steps. For 
example, it is suggested that RIN1 acts as a GEF with preferentially activity for 
Rab5a, the isoform that has been largely implicated in EGFR trafficking (Chen et al., 
2009).  
We also note that GAPex5 and RIN3, two different GEFs of Rab31, have 
different effects on the latter’s localisation and modulation of EGFR trafficking. This 




of a Rab, which may be dependent on its localisation or regulatory domains. In the 
case of Rab31-mediated trafficking of ligand-bound EGFR, GAPex5 appears to play a 
more important role.  
Having seen that Rab31 plays a role in the trafficking of ligand-bound EGFR, 
we then went on to explore what physiological implications this may have. Our 





6. Physiological role of Rab31 in the central nervous system 
6.1 Chapter Introduction: Astrocytic cells and neurogenesis in the brain  
In the embryonic mammalian brain, radial glia (RG), which are believed to 
derive from neuroepithelial cells, develop into the various progenitor cells that will 
eventually give rise to the three main cell types of the brain – the neurons, astrocytes 
and oligodendrocytes (Doetsch, 2003). During development, RG cells can be found in 
the germinal zone of the mouse telencephalon. Their cell soma resides in the 
embryonic germinal zone, while a single long process extends to the pial surface. 
They have both neuroepithelial and astroglial characteristics. For example, they are 
positive for both nestin and glial fibrillary acidic protein (GFAP), markers for 
progenitor and astrocytic cells respectively. RGs serve as neuronal and glial precursor 
cells as the embryonic brain develops (Gregg and Weiss, 2003). While RGs are not 
found in the adult brain, it is believed that as the animal matures, a population of RGs 
retain their neurogenic potential in the adult brain and become the neural progenitor 
cells of the subventricular zone (SVZ) of the lateral ventricles and the subgranular 
zone (SGZ) of the dentate gyrus in the hippocampus, the two main areas of 
neurogenesis in the adult (Alvarez-Buylla et al., 2001). These nestin- and GFAP-
positive cells (Imura et al., 2003) are known as Type B astrocytic cells in the SVZ and 
radial astrocytes in the SGZ, and are believed to be only a subset of the adult 
astrocytic population in this region (Kriegstein and Alvarez-Buylla, 2009; Duan et al., 
2008). When examined by electron microscopy, these cells have the same 
ultrastructural characteristics as typical mature astrocytes, such as intermediate 
filament bundles, vascular end-feet, gap junction complexes and intercalating 
processes between other cell types (Ihrie and Alvarez-Buylla, 2008; Filippov et al., 2003). 




cell types (Liu et al., 2010) during adult neurogenesis. Type B cells, when activated, 
divide and give rise to Type C cells, which are immature precursors that eventually 
give rise to Type A cells, the migrating neuroblasts (García-Verdugo et al., 1998). These 
cells migrate to the olfactory bulb (in rodents) where they differentiate into 
interneurons (their exact target in humans is less well characterised). SGZ astrocytes, 
when stimulated, proliferate and give rise to progenitors (D cells) that mature into 
granule cells (G cells) that migrate to the inner layer and differentiate into 




Fig. 6.1. Cells in the adult mouse neurogenic zones  
Schematic of developmental progression of neural progenitor cells in the adult mouse 
brain and the expression of various markers. SVZ: Subventricular zone; SGZ: 
Subgranular zone. See text for details on Type A, B, C, D and G cells. As: SGZ 
astrocytic cells; GFAP: glial fibrillary acidic protein; EGFR: epidermal growth factor 





Non-progenitor, mature astrocytes exist in the rest of the brain parenchyma. 
These parenchymal astrocytes, the characteristically star-shaped glial cells, are GFAP 
positive but lack nestin. When transplanted into neurogenic regions, they do not 
convert to progenitor cells (Ihrie and Alvarez-Buylla, 2008). They also express S100β, a 
calcium binding protein (Raponi et al., 2007). They are important for the functioning of 
the brain. Among other things, they provide metabolic support for neurons, maintain 
ion concentrations, support the blood-brain barrier and structure the brain. They are 
also important in neurogenesis. Co-cultures show that astrocytes stimulate 
neurogenesis from stem cells isolated from the SVZ and SGZ. This ability might be a 
regional characteristic of these astrocytes, as astrocytes isolated from the spinal cord 
do not have the same effect when co-cultured (Lim and Alvarez-Buylla, 1999; Song et al., 
2002).  
In our initial experiments detailing the expression profile of Rab31 in mouse 
tissues, we found Rab31 to be enriched in the brain (Ng et al., 2009). 
Immunohistochemical analysis revealed that Rab31 could be found in GFAP-positive 
cells in the adult mouse brain, suggesting that they are expressed in astrocytes. In the 
embryonic mouse brain, Rab31 was seen in nestin-positive cells, indicative of radial 
glia. In view of this, we reason that a closer look at a possible physiological role of 
Rab31 in neurogenic areas of the brain would be warranted.  
 
6.2 Results: Rab31 in the adult rodent brain  
The presence of Rab31 in radial glia, which serve as progenitor cells, 
prompted us to investigate whether Rab31 could also be found in neurogenic regions 
of the adult rodent brain. Indeed, immunostaining revealed Rab31-positive cells in 




and the subgranular zone (SGZ) of the hippocampal region which house neural 
progenitor cells (Fig. 6.2A). In a crude dissection of the rat brain to obtain tissue 
lysate from various subregions, we also found that Rab31 to be expressed at high 
levels in the hippocampus by Western blotting (Fig. 6.2B).  
 
Fig. 6.2. Rab31 is found in the neurogenic zones of the adult rodent brain  
A) Adult mouse brain was perfused with 4% paraformaldehyde, sectioned to 20 μm 
thickness on a cryostat and probed for Rab31 (green). SVZ and SGZ were identified 
by brain structural anatomy guided by the nuclear staining (Hoechst 33342, blue). In 
the upper panel, the SGZ lies along the top border of the GL. In the lower panel, the 
SVZ lies in the region between the LV and CC. DG: Dentate gyrus; GL: Granular 
layer; ML: Molecular layer; CC: Corpus callosum; LV: Lateral ventricle. Scale bar = 
40 μm. 
B) Various portions of the adult rat brain were dissected and lysed in extraction 
buffer. 100 μg of lysate was used for Western blot and probed for the various proteins 







Closer inspection of the hippocampal region using immunohistochemistry 
revealed that Rab31-positive cells could be found in both the dentate gyrus (DG) 
region and the CA1 region. These cells were also GFAP-positive, and were thus likely 
to be astrocytic in nature. Neural progenitor cells that are nestin and GFAP-positive 
are believed to reside in the subgranular zone (SGZ) of the DG, while astrocytes in 
the CA1 region are likely to be normal, mature parenchymal astrocytes (Raponi et al., 
2007). While parenchymal astrocytes typically have the characteristic “star” shape, 
progenitor cells in the SGZ of the DG have a more radial-glial like appearance, with 
radial projections into the granular layer (Ihrie and Alvarez-Buylla, 2008). We observed 
that the Rab31-positive cells in the CA1 region were indeed of the typical star shape, 
while Rab31-positive cells in the DG could assume both astrocytic and radial glia 
morphologies (Fig. 6.3).  
We thus took a closer look at the SGZ and attempted to characterise the nature 
of these Rab31-positive cells. The fibres of these Rab31-positive cells are found to 
extend from the SGZ into the granular layer, which is characteristic of the 
neuroprogenitor cells that reside there. These fibres were not TuJ positive (and are 
therefore not neurites) (Fig. 6.4A), but were positive for nestin, a neural progenitor 
marker (Fig. 6.4B). The morphology and marker phenotype suggests that these 
Rab31-positive cells were indeed neural progenitor cells. Perhaps most interestingly, 
these cells were also positive for EGFR (Fig. 6.4C). The presence of EGFR in the 
neurogenic zone has been documented by other groups, and dormant neural 
progenitor cells are believed to express a higher level of EGFR when they are 
activated (Alagappan et al., 2009; Pastrana et al., 2009). The presence of EGFR in GFAP-




cells, or the radial astrocytes, of the SGZ. It is likely that the Rab31-positive cells in 





Fig. 6.3. Rab31 in the hippocampal region of the adult mouse brain  
Adult mouse brain was perfused with 4% paraformaldehyde, sectioned to 20 μm 
thickness on a cryostat and probed with Rab31 (green) and GFAP (red) antibodies. 
DG and CA1 regions were identified by brain structural anatomy guided by the 
nuclear staining (Hoechst 33342, blue). The region of the SGZ is shown in the 
Hoechst-stained panel. Arrowheads indicate star-shaped cells typical of parenchymal 







Fig. 6.4. Rab31-positive cells in the SGZ are not TuJ-positive but are nestin and 
EGFR-positive 
Adult mouse brain was perfused with 4% paraformaldehyde, sectioned to 20 μm 
thickness on a cryostat and probed with Rab31 and various markers as indicated. 
Nuclei are marked by Hoechst 33342 (blue). The region of the SGZ is shown in the 
Hoechst-stained panel.  
A) Arrowhead points to a Rab31-positive radial astrocyte (green) extending into the 
granular layer. Arrow points to a TuJ-positive cell (red). Asterisk indicates a 
parenchymal astrocyte.  
B) Arrows indicate some of the Rab31 (red) and nestin-positive (green) fibres.  
C) Arrow points to a Rab31 (green) and EGFR-positive (red) radial astrocyte. 









6.3 Results: Rab31 in neural progenitor cells 
Rab31 in undifferentiated neural progenitor cells 
Having seen that Rab31 could be found expressed in the neurogenic areas of 
the adult rodent brain, we asked what roles Rab31 might have in the neural progenitor 
cells. To investigate this, we used cultured neural progenitor cells (NPC) harvested 
from E15 mice, which would provide a platform for in vitro manipulation. These E15 
NPCs are multipotent, EGF-responsive, and can be cultured for several passages as 
neurospheres. They are positive for nestin and PCNA, markers of radial glia and 
proliferating cells respectively. NPCs can also be induced to differentiate in various 
media that favour either the differentiation to astrocytes or neurons, respectively 
(Chojnacki and Weiss, 2008; Low et al., 2012).  
In our cultured NPCs, Rab31 was found in the undifferentiated NPC at the 
perinuclear region (colocalising with the Golgi marker GM130) in most, if not all, 
cells. This Rab31-positive staining was obliterated when cells were transfected with 
Rab31 siRNA, showing that the staining is indeed specific for Rab31 (Fig. 6.5). These 
NPCs were also positive for both the progenitor cell-specific intermediate filament 
protein nestin (Fig. 6.6A) and proliferating cell nuclear antigen (PCNA) (Fig. 6.6B). 
These cells also appear to have moderate levels of EGFR (Fig. 6.6C). These latter 












Fig. 6.5. Rab31 is expressed and localised to the perinuclear region in 
undifferentiated neural progenitor cells (NPC)  
Mouse NPC were isolated from E15 mouse brain. Undifferentiated cells were plated, 
and transfected with scrambled (Scr) or Rab31 siRNA as indicated. Due to difficulty 
in picking up the Rab31 signal by Western blot of NPC lysates, depletion of Rab31 
was quantified by RT-PCR after 48 h. Rab31 was 85% depleted as quantified by 
Image J. Cells were also fixed and probed for Rab31 (green) and GM130 (red). 
Arrowheads indicate examples of perinuclear Rab31 in the upper panel, which is not 







Fig. 6.6. Rab31- positive NPCs are positive for nestin, PCNA and EGFR 
Mouse NPC were isolated from E15 mouse brain. Undifferentiated cells were plated, 
fixed and probed for Rab31 (green) and the various markers indicated (red). Scale bar 
= 20 μm. 
 
Rab31 in differentiated neural progenitor cells  
We next asked if Rab31 level changes, as the NPCs were induced to 
differentiate. Quantitative real-time PCR analysis of Rab31 mRNA transcripts as cells 
differentiated showed that Rab31 levels dropped transiently, but then increased, as 
NPCs differentiated to astrocytes, along with increasing GFAP levels and decreasing 
nestin levels. The changes seen were corroborated by immunofluorescence 
microscopy observations (Fig. 6.7). This observation therefore suggests that Rab31 









Fig. 6.7. Rab31 levels change in NPC induced to differentiate  
A) Mouse NPCs were induced to differentiate to astrocytes. Total mRNA was 
harvested from cells at various time points indicated. Quantitative real-time PCR was 
used to determine the changes in mRNA levels of Rab31, GFAP, and nestin, 
normalised to Glyceraldehyde 3-phosphate dehydrogenase (G3PDH) and represented 
as fold changes compared to the 0 h time point. Three independent experiments were 
performed and data is shown as mean ± SEM.  
B) Cells were fixed at various times indicated and probed for Rab31 (green) and 






In looking at how Rab31 levels change with differentiation, we observed that a 
subset of the GFAP-positive astrocytes obtained after differentiation were strongly 
immunopositive for Rab31. We thus took a closer look at this phenomenon. We 
allowed the NPCs to differentiate under 2 different conditions, one which promotes 
greater astrocytic differentiation and one which promotes greater neuronal 
differentiation. In both sets of differentiation conditions, we observed that Rab31 is 
found in elevated levels in a subset of the GFAP-positive population, but not in TuJ-
positive cells examined (Fig. 6.8). The Rab31-positive cells also do not express 2’, 3’-
cyclic nucleotide 3’-phosphodiesterase (CNPase), the marker for oligodendrocytes 
(Fig. 6.9A), or doublecortin (DCX), the marker for immature neurons (Fig. 6.9B). We 
also noted that these cells were now delocalised with cells positive for PCNA or 
EGFR (Fig. 6.10), indicating that these cells were no longer dividing progenitors. We 
quantified the number of GFAP-positive cells that highly express Rab31 and found 
that they constituted only a subset of the total GFAP-positive population (Fig. 6.11), 
as compared to in the undifferentiated NPC where the perinuclear Rab31 is seen in 
most, if not all, cells. These observations indicate that Rab31 is expressed in NPCs, 
but its expression is diminished as the NPC population differentiates. Its expression is 
then re-established when NPCs differentiate into astrocytes, but not when NPCs 
differentiate into neurons or other cell types. These observations are consistent with 







Fig. 6.8. Rab31 levels are elevated in a subset of GFAP-positive cells when NPCs are 
induced to differentiate  
Mouse NPC were isolated from E15 mouse brain, plated and induced to differentiate 
under various conditions for 5 days, before fixation and immunofluorescence analysis. 
Cells were probed for Rab31 (green) and GFAP or TuJ (red). Rab31 is highly 
expressed in a subset of GFAP-positive cells but not TuJ positive cells, in both types 







Fig. 6.9. Elevated Rab31 levels are not found in CNPase and DCX-positive cells in 
NPC induced to differentiate  
A) Mouse NPC were isolated from E15 mouse brain, plated and induced to 
differentiate under various conditions for 5 days, before fixation and 
immunofluorescence analysis. Cells were probed for Rab31 (red) and CNPase 
(green). Scale bar = 20 μm. 
B) Mouse NPCs were isolated from E15 mouse brain, plated and induced to 
differentiate for 5 days, before fixation and immunofluorescence analysis. Cells were 









Fig. 6.10. Cells with elevated Rab31 levels are delocalised from cells that are still 
PCNA and EGFR-positive in NPC induced to differentiate  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and induced to differentiate. Cells were fixed and probed for Rab31 and various 
markers as indicated. Arrows indicate PCNA or EGFR positive cells; arrowhead 
points to a Rab31-positive cell. Nuclei were visualised with Hoechst 33342 (blue). 





Fig. 6.11. Percentage of cells with elevated levels of Rab31 in NPC induced to 
differentiate  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated, 
and induced to differentiate. Cells were fixed and probed for Rab31 and GFAP. 
Number of Rab31-positive cells was quantified and presented graphically as a 
percentage of total cells and total GFAP-positive cells counted, respectively. 38 cells 




















Effect of Rab31 depletion and overexpression on differentiation of neural progenitor 
cells 
From the findings  above, we can perhaps postulate 2 potential roles for  
Rab31: a) Given the ubiquitous presence of Rab31 in undifferentiated NPC and its 
initial diminishment as cells differentiate, Rab31 may help to maintain NPCs in an 
undifferentiated form; b) The subsequent increase in Rab31 levels in a subset of 
astrocytic cells suggests that Rab31 may also be a cell fate determinant for the 
differentiation of NPCs to astrocytes versus neurons, and perhaps also the subtype of 
astrocytes that emerges at the end.  
To investigate the first possibility, we silenced Rab31 expression using GFP-
tagged Rab31 shRNA and enhanced the rate of shRNA introduction into the NPCs by 
using retroviral transduction, and maintained these cells in EGF- and fibroblast 
growth factor 2 (FGF-2)-supplemented culture (Fig. 6.12). After 48 h, we investigated 
if there was extraneous differentiation observed in NPCs in which Rab31 was 
depleted, and found no morphological evidence that loss of Rab31 would itself induce 
cells to differentiate, as assessed by staining with nestin (Fig. 6.13A). This was 
corroborated by a Western blot which showed no decrease in nestin and PCNA levels 
(Fig. 6.13B). We also investigated if the converse treatment, i.e. Rab31 
overexpression (Rab31 OE), would affect the undifferentiated state of NPCs. 
Transfection with Myc-Rab31 did not affect the NPCs in an undifferentiated state, 
which remained nestin-positive (Fig. 6.14). Together, the results suggest that 
manipulation of the levels of Rab31 does not have a significant impact on the 







Fig. 6.12. Depletion of Rab31 by GFP-tagged shRNA retroviral transduction  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and cultured with medium containing control (Ctrl) or GFP-Rab31 shRNA 
retroviruses. After 48 h, cells were fixed and immunofluorescence staining was 
performed to assess extent of Rab31 depletion. In the Rab31 shRNA panel, arrows 
indicate GFP-positive cells (green), where Rab31 (red) staining is not present, in 
contrast with arrowheads which indicate non-transduced cells where Rab31 staining 









Fig. 6.13. Depletion of Rab31 does not affect undifferentiated state in NPCs 
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and cultured with medium containing Ctrl or GFP-Rab31 shRNA retroviruses.  
A) After 48 h, cells were fixed and immunofluorescence staining for nestin (red) was 
performed. Scale bar = 20 μm. 
B) Cells were also harvested for cell lysate and analysed by Western blot for nestin, 
PCNA, and γ-tubulin. 
 
 
Fig. 6.14. Myc-Rab31 overexpression did not spontaneously induce NPCs to 
differentiate 
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and transfected with Myc-Rab31. After 48 h, cells were fixed and probed for Rab31 







We next investigated whether Rab31 played a deterministic role in the 
differentiation of NPCs. In conditions suited for both astrocyte and neuronal 
differentiation, there were significantly fewer GFAP-positive cells obtained when 
Rab31 was silenced (as indicated by the presence of GFP), compared to controls (Fig. 
6.15A). We quantified this and found that in cells with Rab31 depletion there was a 
reduced percentage of GFAP-positive cells obtained (Fig. 6.15B). There was no 
difference in the percentage of DCX-positive cells (Fig. 6.16). We then overexpressed 
Rab31 and induced the NPC to differentiate (Fig. 6.17). (As there was little 
observable difference between cultures in which astrocyte or neuronal-favouring 
differentiation medium was used, subsequent data shown is from experiments 
performed with astrocyte-favouring differentiation medium). Overexpression of 
Rab31 (Rab31 OE) enhanced the percentage of GFAP-positive astrocytes. Together, 
the results suggest that depletion of Rab31 reduces, while overexpression of Rab31 
enhances, the percentage of GFAP-positive astrocytes obtained when NPCs are 
induced to differentiate (Fig. 6.18). It is therefore likely that Rab31 is important for 


















Fig. 6.15. Depletion of Rab31 by GFP-tagged shRNA retroviral transduction reduced 
the number of GFAP-positive cells obtained when NPCs were induced to differentiate  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and cultured with medium containing Ctrl or GFP-Rab31 shRNA retroviruses. After 
48 h, cells were induced to differentiate as indicated.  
A) After 5 days cells were fixed and immunostained for GFAP (red). Cells that have 
taken up the retroviral shRNA express GFP (green). Scale bar = 20 μm.  
B) Number of GFAP-positive cells was quantified and presented graphically as a 
percentage of total cells counted. Left panel is obtained from cells cultured in medium 
favouring astrocyte differentiation while right panel is obtained from that favouring 
neuronal differentiation. White bars represent counts from cells cultured with medium 
containing the control shRNA retroviruses (Ctrl) while shaded bars represent counts 
from cells cultured with Rab31 shRNA retroviruses. 35 cells in 3 independent 
experiments were analysed and data is shown as mean ± SEM. *P<0.05, **P<0.01 






Fig. 6.16. Depletion of Rab31 by GFP-tagged shRNA retroviral transduction did not 
affect the percentage of DCX-positive cells obtained when NPCs were induced to 
differentiate 
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and cultured with medium containing Ctrl or GFP-Rab31 shRNA retroviruses. After 
48 h, cells were induced to differentiate as indicated. After 5 days cells were fixed and 
immunostained for DCX (red). Cells that have taken up the retroviral shRNA express 







Fig. 6.17. Cells overexpressing Myc-Rab31 also express GFAP when NPCs were 
induced to differentiate  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and transfected with Myc-Rab31. After 48 hours, cells were induced to differentiate. 
After 5 days cells were fixed and immunofluorescence staining for Rab31 (green) and 





Fig. 6.18. Effect of manipulation of Rab31 levels on differentiation of NPCs 
NPCs were treated as indicated and induced to differentiate after 48 h. Cells were 
maintained in culture for 5 days before fixing and immunofluorescence staining for 
GFAP. Number of GFAP-positive cells was quantified and presented graphically as a 
percentage of total treated cells counted. Treated cells were identified by the Myc-
Rab31 expression (for Rab31 OE) or the GFP expression (for shRNA-treated cells).  
42 cells in 3 independent experiments were analysed and data is shown as mean ± 





















Effect of EGF withdrawal on differentiation of neural progenitor cells 
As presented and discussed in Chapters 4 and 5, Rab31 plays a role in the 
trafficking of ligand-bound EGFR.  Depletion of Rab31 delayed the degradation of 
EGFR, by hindering its entry into late endosomes, while overexpression of Rab31 
enhanced the degradation (Fig. 4.8B). It is conceivable that the effect of Rab31 on the 
differentiation of NPCs was due to its role in EGFR trafficking. Increased levels of 
Rab31 increase the degradation of EGFR, thus decreasing the time which ligand-
bound EGFR is able to signal. This could in turn affect the differentiation programme 
when cells were induced to differentiate, as EGFR signalling plays an important role 
in the proliferation and differentiation of progenitor cells. We postulated that a 
withdrawal of EGF from the media in which NPCs were cultured may crudely mimic 
the situation in which Rab31 was overexpressed in these cells. However, when we 
first withdrew EGF from the media in which the undifferentiated NPCs were cultured, 
and then induced the NPC to differentiate, we found that the number of GFAP-
positive astrocytes obtained was reduced (Fig. 6.19A). We quantified this and found 
that EGF withdrawal from the media for undifferentiated NPC subsequently reduced 
the percentage of GFAP-positive cells obtained when the NPC were induced to 
differentiate (Fig. 6.19B), rather than increased in the case of a Rab31 overexpression. 






 Fig. 6.19. Withdrawal of EGF from NPC culture media before differentiation 
reduced the number of astrocytes obtained  
Mouse NPCs were isolated from E15 mouse brain. Undifferentiated cells were plated 
and EGF was withdrawn from the culture med    ia. After 48 hours, cells were induced 
to differentiate.  
A) After 5 days cells were fixed and immunofluorescence staining for GFAP (red) 
was performed. Nuclei were visualised with Hoechst 33342. Scale bar = 20 μm. 
B) Number of GFAP-positive cells was quantified and presented graphically as a 
percentage of total cells counted. 32 cells in 3 independent experiments were analysed 
























6.4 Chapter Discussion: Possible role of Rab31 in NPCs and astrocytes 
Role of Rab31 in NPCs 
Our results suggest that Rab31 exerts a positive influence on the generation of 
astrocytes from neural progenitors, and has therefore a distinct physiological role to 
play in the mammalian brain. At present, the mechanism by which Rab31 exerts its 
effect is not known. We could postulate that it may be linked to the role of Rab31 in 
EGFR trafficking as shown in A431 and HeLa cells, in which Rab31 depletion 
reduced, while Rab31 overexpression enhanced, the movement of EGFR into late 
endosomes, thus affecting its eventual degradation in lysosomes.  
EGFR signalling is important to the survival and function of NPCs. The 
amount and effect of EGFR signalling varies during different stages of development. 
At early stages, a low level of EGFR signalling was shown to be required for 
proliferation of neural progenitor cells (Liu and Neufeld, 2007). Overexpression of 
EGFR (via retroviral transduction in vitro and in vivo) at this stage causes NPCs to 
present the characteristics of differentiating astrocytes at later stages (Burrows et al., 
1997). Our observation of the presence of Rab31 in NPCs (Fig. 6.6) may thus reflect 
their role in a fast turnover of ligand-bound EGFR, keeping EGFR signalling at a low 
level required for the proliferation of neural progenitor cells. Because of the elongated 
nature of NPCs and the lack of antibodies suited for immunocytochemical observation 
of endocytic trafficking in this cell type, we were unable, at this point, to fully explore 
the dynamic nature of Rab31-mediated EGFR trafficking in NPCs. Although in our 
hands manipulating Rab31 levels did not affect the undifferentiated state of NPCs, 
this may simply be a result of other feedback or redundancy mechanisms in place.  
At later stages of embryonic development, high level of EGFR signalling is 




EGFR and its ligands gradually increase in the developing CNS, coincident with 
gliogenesis (Tropepe et al., 1999; Kornblum et al., 1997). Furthermore, during 
asymmetrical division of progenitor cells, daughter cells with high EGFR levels 
become astrocytes while those with low levels become oligodendrocytes (Sun et al., 
2005). In our observations, when NPCs are induced to differentiate, Rab31 levels 
show a dip initially (Fig. 6.8). This may aid in reducing the rate of degradation of 
ligand-bound EGFR, prolonging the effect of its signalling, to enable the 
differentiation to astrocytes.  
A role in regulating the duration of EGFR signalling, however, cannot 
properly explain why Rab31 depletion would decrease (rather than increase) the 
eventual number of astrocytes obtained, and vice versa. One possible reason could be 
linked to a recent observation that EGF signalling, while enhancing the progression of 
radial glia to immature astrocytes (which are both nestin- and GFAP-positive), 
subsequently inhibits the progression from immature astrocytes to mature astrocytes 
(which express S100β along with GFAP) (Raponi et al., 2007). The increase in EGFR 
signalling caused by our Rab31 depletion studies might have resulted in a hindrance 
to the complete development of the astrocytes in culture, thus resulting in a decreased 
percentage of astrocytes that survive in culture.   
Although we attempted to further explore the idea of a Rab31-EGFR effect on 
astrocytic differentiation by withdrawing EGF from the culture medium, we were 
unable to show a similar effect to Rab31 overexpression. One possible explanation for 
this is that EGF withdrawal is a poor mimic of the effect of overexpression of Rab31. 
Firstly, although EGF is removed from the growth media, the FBS used in the 
differentiation media also contains an undefined amount of growth factors. Secondly, 




but rather alters its strength and/or duration. Thirdly, manipulation of Rab31 levels 
may alter subtle balances in trafficking or trigger feedback mechanisms that affect 
EGFR signalling or trafficking in unexpected ways. We should also note that besides 
EGF, a myriad of other factors are involved in signalling in NPCs, including FGF-2, 
platelet derived growth factor (PDGF) and TGFα (Jackson et al., 2006). While we have 
found that Rab31 does not participate in the trafficking of FGF receptor and PDGF 
receptor (data not shown), TGFα also binds to EGFR and its signalling may therefore 
also be affected by Rab31.   
Ultimately, it is the specific combination of ligand and receptor levels, at 
different stages of embryonic development, which determine the response of neural 
progenitor cells. To gain a better understanding of how Rab31 affects this process, we 
would need to manipulate Rab31 levels at various stages in embryonic development 
in vivo. Conceivably, manipulating Rab31 levels (and hence EGFR signalling) during 
the stage at which proliferation of NPCs predominates would differ from stages at 
which neurons are being generated, which in turn would differ from the early 
postnatal stages at which more glial cells are being generated.  
In the adult mouse brain, NPCs are generally quiescent until activated, at 
which time they upregulate EGFR and become EGF responsive (Pastrana et al., 2009; 
Alagappan et al., 2009). This results in enhanced proliferation and migration 
capabilities, and reduced differentiation (Ayuso-Sacido et al., 2010). The reason for the 
high levels of Rab31 observed in these quiescent NPCs in our adult mouse brain 
cryosection is unclear, given that the quiescent cells are not EGF-responsive. It is 
possible that Rab31 has a role separate from that of EGFR trafficking in these cells, or 
that they regulate a low, constitutive level of EGFR signalling present in these cells. It 




would be interesting to observe how Rab31 levels in the neurogenic zones of the adult 
mouse brain might change during CNS injury, and whether manipulation of their 
levels would affect the response of the quiescent NPCs to injury.  
 
Role of Rab31 in astrocytes 
We have also observed Rab31 in astrocytes in the adult mouse brain and in a 
subset of GFAP-positive cells in our NPC culture induced to differentiate. EGFR 
signalling induces astrocytes to provide a permissive environment for neurite 
outgrowth in the developing CNS (Liu and Neufeld, 2004). In the adult CNS, EGFR is 
absent from mature astrocytes (Gómez-Pinilla et al., 1988) but reappears together with 
nestin (Herrmann and Aebi, 2000) in reactive astrocytes in response to injury, which 
changes their phenotypic characteristics (Liu and Neufeld, 2007; Liu, 2006). Notably, 
these astrocytes are distinct from those believed to be neural progenitors, as they also 
express S100β, which is a distinct marker for mature astrocytes (Cho et al., 2013; Ihrie 
and Alvarez-Buylla, 2008). At present the reason for the high levels of Rab31 seen in a 
subset of astrocytes in our adult mouse brain cryosection and differentiated NPC 
culture is not known. Given that EGFR signalling is very much reduced in mature 
astrocytes, the enrichment of Rab31 in a subset of the astrocytic population, even 
those outside of the neurogenic regions, may be reflective of a separate role of Rab31 
from EGFR trafficking. Rabs, for example, are believed to play a role in the 
exocytosis of neuropeptides or  the recycling of transporters, such as the glutamate-
aspartate transporter, on astrocytic membranes (Kreft et al., 2009). Rab31 may play an 
as-yet-unknown role in these areas.  It would also be interesting to see how Rab31 
levels change in parenchymal astrocytes in the injured CNS, when the astrocytes 




7. Conclusion and future perspectives 
7.1 General conclusions  
In this thesis, Chapter 3 describes attempts in exploring some of the possible 
mechanisms by which Rab31 is faithfully localised to the trans-Golgi network, and 
we show that it is a combination of functional domains and interacting proteins that 
mediate this process. Interestingly, we found that two different GEFs of Rab31, 
GAPex5 and RIN3, had different influences on Rab31 localisation. We also observed 
that Rab31 could also be localised, in part, to the endosomal network. Given that 
other members of the Rab5 subfamily (to which Rab31 belongs) participate in 
endocytic trafficking steps, including those of cell surface receptors such as EGFR, 
we sought to investigate the participation of Rab31 in the endocytic trafficking of 
EGFR. We show in Chapter 4 and 5 that Rab31 participates in the transition of ligand-
bound, internalised EGFR from the early to late endosome, by engaging in a 
trafficking complex that includes EGFR and EEA1.  
These results are intriguing for several reasons. Firstly, it suggests that 
although Rab31 is largely and primarily localised to the TGN, there is a fraction 
found on what is likely to be endosomes, and this endosomal pool of Rab31 might 
possibly play a physiological role in the cell. Some groups have suggested that Rab31 
moves from the TGN onto tubulovesicular structures and is responsible for 
anterograde transport between the TGN and endosomes (Rodriguez-Gabin et al., 2001). 
Here, we provide evidence that Rab31 also plays a role in retrograde transport in the 
endocytic pathway. Secondly, Rab31 appears to be part of a larger trafficking 
complex that includes both EGFR and EEA1. Previously, Rab25 and Rab21 were the 
only Rabs thus far that have been shown to interact directly with cell surface receptors, 




our results indicate that Rab31 is a player in the endocytic trafficking pathway of 
EGFR. We postulate that the formation of Rab31-EGFR trafficking complex, together 
with EEA1, is subsequently essential for the entry of the ligand-bound receptor into 
the late endosomes. This is perhaps similar to the role that has been recently 
postulated for Rab21, although in the case of Rab21 it appears that it functions in a 
ligand-independent manner as well, enhancing the degradation of unliganded EGFR 
(Yang et al., 2012).  
The exact mechanism by which Rab31 is engaged on early endosomes 
remains to be fully elucidated. GAPex5 may be important for this process. GAPex5 
has been shown to bind to EGFR via Cbl (Su et al., 2007), an E3 ubiqutin ligase 
responsible for the ubiquitination of EGFR, which serves as both an internalisation 
and degradation signal.  It  is possible that the presence of GAPex5 on EGFR is 
responsible for recruiting and activating Rab31 from the cytosol onto EGFR-carrying 
endosomes. Once there, activated Rab31 can engage its effectors such as EEA1. We 
also show in Section 4.2 that Rab31 plays a role downstream of Rab5 in the endocytic 
trafficking of EGFR, and we speculate that Rab31 might perhaps be recruited to the 
EGFR trafficking complex subsequent to the involvement of Rab5. As EEA1 is also a 
Rab5 effector, Rab5 may be responsible for first engaging EEA1 onto EGFR-carrying 
endosomes, which then later interacts with the activated Rab31. How the 
Rab31/EEA1/EGFR trafficking complex subsequently mediates the movement of 
ligand-bound EGFR from early to late endosomes also remains to be explored. EEA1 
may perhaps be subsequently involved in the recruitment of other late endosome 
markers, or in facilitating the tethering of endosomes. Fig. 7.1 illustrates the possible 




Fig. 7.1. Illustration of Rab31 interactions in ligand-bound EGFR trafficking  
A) Ligand-bound EGFR is internalised into early endosomes (EE) from the plasma 
membrane (PM). EEA1 and Rab5 may already be present on the EE.  
B) GAPex5 is bound to EGFR via Cbl. GAPex5 stimulates Rab31 GDP-GTP 
exchange, allowing Rab31 to engage its effector, EEA1 on the endosome.  
C) Subsequently, other complexes, together with Rab31-EEA1-EGFR, may mediate 
the movement to late endosomes.  
For simplicity only relevant protein complexes on the ligand-bound EGFR is shown, 










We also show in Section 4.3 that Rab31 may indirectly impinge on the 
recycling of ligand-bound EGFR. Since Rab31 appears to mediate the trafficking of 
ligand-bound EGFR between early and late endosomes, Rab31 depletion would result 
in a decrease in channelling to the late endosome-lysosome pathway and instead 
shunts more ligand-bound EGFR to the recycling endosomes, and the converse could 
be expected for Rab31 overexpression. The extent to which Rab31 determines the 
rates of recycling versus degradation remains to be fully explored. Several other 
mechanisms have been identified which regulate the levels of EGFR recycling and 
degradation that occurs in the cell. For example, it was shown that ligand-bound 
EGFR can be internalised by both clathrin-mediated endocytosis (CME) and clathrin-
independent mechanisms, with CME predominating the response to low levels of 
EGF, which in turn was linked to higher levels (~70%) of recycling compared to 
degradation (Sigismund et al., 2008). It is not yet known whether Rab31 influences the 
channelling of ligand-bound EGFR in the endosomes downstream of either or both 
CME and non CME-mediated pathways.  
We provide evidence in Section 5.3 that the role of Rab31 in EGFR trafficking 
is mediated by the GEF GAPex5, but not RIN3. Instead, the loss of RIN3 appears to 
affect the localisation of M6PR, in cells with Rab31 overexpression. The exact 
reasons for this remain to be explored, but may be linked to observations by other 
groups that Rab31 also participates in the anterograde transport of M6PR from the 
TGN (Rodriguez-Gabin et al., 2001; Rodriguez-Gabin et al., 2009). Regardless, our 
observation highlights the importance of GEFs in mediating the specificity of Rab 
localisation and function. This is particularly significant given that we observed RIN3 
to be faithfully localised to the TGN, but GAPex5 to have a more cytosolic 




roles of Rabs can be found in the DENN-domain containing connecdenns, which 
serve as GEFs for Rab35 (Marat and McPherson, 2010). Rab35 has a range of 
activities on the plasma membrane, clathrin coated pits, and endosomes, and regulates 
endocytic recycling and actin remodelling. Connecdenn 1 and 2 are localised to 
punctate structures and are believed to activate Rab35’s role on endosomes, while 
connecdenn 3 has a unique actin-binding domain not found in the other two, which 
enables it to mediate Rab35’s actin-related activity. Connecdenn 3 is first recruited to 
actin, after which it mediates GDP-to-GTP exchange on Rab35, enabling Rab35 to 
recruit its effector, fascin, resulting in the bundling of actin filaments (Marat et al., 
2012). As another example, Rab5’s GDP-GTP exchange can be aided by Rabex5 on 
endosomes, which is stabilized by its ability to interact with Rabaptin5, whereas RIN1 
has been accorded a more specific role in regulating Rab5-mediated endocytosis of 
EGFR, due to the presence of SH2 and Ras association (RA) domains (van der Bliek, 
2005; Carney et al., 2006).  From these examples, it is evident that further exploration 
into the different regulatory domains on GAPex5 and RIN3, as well as other GEFs of 
Rab31 that come to light, will be instrumental in delineating the different roles of 
Rab31 in regulating TGN- and endosomal- related trafficking. 
In Chapter 6 we explored the physiological relevance of Rab31 by showing 
that Rab31 plays a role in the differentiation of neural progenitor cells (NPCs). Rab31 
is expressed in NPCs in the mouse brain. In culture, Rab31 is found in 
undifferentiated neural progenitor cells, and manipulation of Rab31 levels affects the 
subsequent differentiation of these cells into those of the astroglial lineage. This is the 
first time Rab31 has been shown to play a role in neural progenitor cells, and is, to our 
knowledge, the first indication for a role of a Rab GTPase in astroglia differentiation. 




remains to be fully explored. Manipulation of the known GEFs of Rab31 and tracing 
the movement of EGFR after an EGF pulse in NPCs might give some insight into 
how Rab31 activity is important to these cells.  
Additionally, the reason for the high levels of Rab31 seen in a subset of 
astrocytes in our adult mouse brain cryosection and differentiated NPC culture 
remains to be explored. While matured astrocytes are not normally EGF-responsive, 
trafficking of other receptors or cell surface proteins do take place, in which Rab31 
could play an important role. For example, astrocytes carry the p75 neurotrophin 
receptor (p75 NTR) which is trafficked in response to ligand binding (Cragnolini et al., 
2009).  p75 NTR was recently shown to interact with Rab31, in the context of 
adipocytes (Baeza-Raja et al., 2012). Although this occurred in a neurotrophin-
independent manner and does not involve the trafficking of the receptor, it is 
conceivable that in the context of astrocytes, Rab31 might be responsible in regulating 
the trafficking of p75 NTR. Increasing evidence suggests that Rabs mediate more than 
one role in the cell, such as the example of Rab35 discussed above. As such, it is not 
surprising that Rab31 would also be associated with different roles in different cell 
types.  
In summary, we have observed the two potential roles of Rab31 in EGFR 
trafficking and neural progenitor cell differentiation. These are likely to impact the 
study of both neurogenesis and tumourigenesis, as discussed in the following section.  
 
7.2 Applications and implications of our findings 
Neurogenesis serves learning and memory, and also has roles for repair in 
pathological states (Duan et al., 2008), and as such has many important applications. 




transplantation therapy. However, one problem frequently encountered is that 
astrogliosis is often triggered in an injured CNS environment (Chen and Swanson, 2003; 
Floyd, 2012). Astrogliosis results in changes to the molecular expression and 
morphology of astrocytes, which result in hyper-proliferation and eventual scar 
formation. This in turn inhibits axon or neuronal regeneration. Our results indicate 
that depletion of Rab31 in NPCs can attenuate astroglia formation. It is therefore 
conceivable that manipulation of Rab31 levels in NPCs before transplantation into a 
site of traumatic CNS injury could aid in improving neuronal differentiation and 
neurite growth. Moreover, it has been shown that blocking EGFR activation in 
astrocytes is beneficial for neuronal survival in cases of traumatic CNS injury, as it 
minimises the activation of reactive astrocytes (Liu and Neufeld, 2007). Since Rab31 
has been associated with EGFR trafficking, manipulation of Rab31 levels in mature 
astrocytes might also prove beneficial.   
It has also been shown that myelin-associated inhibitors and chondroitin 
sulphate proteoglycans from the glial scar, which act to inhibit axonal regeneration, 
act on neurons through EGFR signalling pathways (Koprivica, 2005). Although our 
current research has focussed on Rab31 in NPCs and astrocytes rather than neurons, 
and the extent of Rab31 expression in neurons is unknown, it is also possible that 
manipulation of EGFR trafficking pathways via Rab31 in neurons might be one way 
to overcome the inhibition posed by myelin and glial scar inhibitors. 
The flipside to neurogenesis is tumourigenesis, which also has strong links to 
EGFR signalling. Glioblastoma multiforme (GBM) is a form of brain cancer caused 
by malignant glioma. NPCs are believed to be the cell of origin of GBM tumour stem 
cells. EGFR has been frequently found to be amplified in 45% of GBM. Mutations 




in the extracellular domain, resulting in a ligand-independent, constitutively activated 
kinase (Ayuso-Sacido et al., 2006). As such, many cancer therapies rely on the blocking 
of EGFR signalling. Antibodies such as Cetuximab have been developed, as well as 
small molecule inhibitors of EGFR tyrosine kinase, such as Gefitinib, which binds to 
the ATP-binding site of the kinase. In studies done in U87 cells, a glioblastoma cell 
line, the authors identified Mig6 as a potential tumour suppressor. Mig6 enhances 
EGFR trafficking to the late endosome and lysosome by binding to Syntaxin 8, a 
SNARE protein that mediates late endosome trafficking (Ying et al., 2010). As Rab31 
acts on a similar step in EGFR trafficking, it is conceivable that it may also be 
important in tumourigenesis, perhaps as a tumour suppressor.  
Interestingly, however, Rab31 has been shown to be of value as a biomarker in 
GBM (Serão et al., 2011), and was recently found to be upregulated in GBM (Kunkle et 
al., 2013). Rab31 was also shown to have prognostic values in breast cancer and 
elevated levels have been associated with poorer survival outcomes (Kotzsch et al., 
2008; Kotzsch et al., 2011). Rab31 is also differentially overexpressed in estrogen 
receptor α (ERα)-positive breast carcinomas (Abba et al., 2005). As such, Rab31 
appears, in fact, to be elevated in many cancers. Several reasons for this have recently 
come to light. Firstly, the Rab31 promoter has been shown to have an estrogen 
receptor responsive element, and may therefore be controlled by associated trans 
factors. Indeed, it has been shown that mucin-1 (MUC1), which is overexpressed in 
many human cancer cells, forms a complex with ERα that both stabilises ERα by 
blocking its ubiquitination and activates Rab31 transcription (Jin et al., 2012), thus 
suggesting that Rab31 may be an oncogenic driver for ERα breast cancers. 
Interestingly, the study also found that Rab31, in turn, resulted in elevated levels of 




degradation of MUC1 via an as-yet-undefined mechanism, thus forming a potential 
auto-inductive loop. In the future we would seek to investigate how Rab31 can 
influence the trafficking of MUC1. 
On the other hand, other studies have shown that overexpression of Rab31 in 
breast cancer cell lines switched these from an invasive to a proliferative phenotype, 
and significantly reduced lung cancer metastasis in a mouse xenograft model 
(Grismayer et al., 2012). This again highlights the complexity of responses in 
manipulation of a single protein involved in the multifaceted pathways of oncogenesis.  
How might we reconcile the evidence that Rab31 may be an oncogenesis-
related protein with our own observations that in A431 and HeLa cells, Rab31 appears 
to downregulate EGFR (an important oncogenesis-related signal), via its role in the 
early-to-late endosome trafficking of ligand-bound EGFR? One reason could be due 
to differences in cell type, and the associated differences in levels of Rab31 GEFs like 
GAPex5, and also hitherto unknown GAPs. Rab25, for example, has also been 
alternately identified as an oncogene or a tumour suppressor, and the general 
consensus is that its role in cancer is largely context dependent, possibly in part due to 
the expression levels of its effector, Rab Coupling Protein (RCP) (Tang, 2010; Mitra et 
al., 2012). Likewise, in contrast to breast cancer, Rab31 was shown to have no 
prognostic value in ovarian cancer (Kotzsch et al., 2008; Kotzsch et al., 2011). Also, 
multiple mutations in cancer cell lines, especially in EGFR itself, may alter the way in 
which Rab31 affects EGFR trafficking and signalling. Moreover, as described above, 
Rab31 also affects MUC1 levels (Jin et al., 2012). As MUC1 itself has also been shown 
to bind EGFR and potentiate its signalling by reducing ubiquitination (Pochampalli et 
al., 2007), the net effect of Rab31, MUC1 and EGFR in pre-cancerous and cancerous 




Rab31, MUC1 and EGFR. Manipulation of Rab31 may, in the future, be a tenable 




Fig. 7.2. Interactions between Rab31, EGFR and MUC1 
(A) In the nucleus, MUC1 enhances the transcription of Rab31 by stabilising the ERα 
transcription factor.  
(B) In the cytosol, Rab31 enhances the stability of MUC1 by decreasing its lysosomal 
degradation.  
(C) Rab31 facilitates the trafficking of ligand-bound EGFR from early to late 
endosome.  
(D) MUC1 potentiates ligand-bound EGFR signalling by reducing the ubiquitination 
and hence degradation of EGFR, thus enhancing the recycling of EGFR to the cell 
surface. 
PM: Plasma membrane, EE: early endosome, LE: late endosome.  







Because of the multivariate effects of EGFR signalling in neurodevelopment 
as well as tumour progression, manipulation of EGFR signalling in therapeutic 
strategies must be tempered with caution and a better understanding of how the 
signalling is regulated. To this end, deciphering the exact cellular roles and activities 
of Rab31 is therefore important.  
In conclusion, our results indicate that Rab31 is a hitherto underappreciated 
and important player in the endocytic trafficking of EGFR which functions in an 
EGFR trafficking complex together EEA1 and GAPex5. It could conceivably be 
anticipated that alterations in Rab31 expression or activity, which has been 
documented in various cancers (Kotzsch et al., 2008; Grismayer et al., 2012; Kunkle et al., 
2013), will affect EGFR trafficking and signalling in ways that may contribute to 
malignancy and metastasis. Rab31 also appears to have a role in astroglia 
differentiation, perhaps through regulation of EGFR trafficking and signaling, a 
notion that has yet to be fully explored. Further work along these lines would prove to 
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Appendix 1 – Plasmid vectors 
Plasmid maps of vactors used for mammalian gene expression. Images are reproduced 




pCI-neo: Expression is driven by the human cytomegalovirus (CMV) immediate-
early enhancer/promoter. Transfected cells can be selected with the antiboiotic G418. 
The expression vector pDMyc is modified from pCI-neo to include the myc 





pEGFP-C1: Expression is driven by the human cytomegalovirus (CMV) immediate-
early enhancer/promoter. Transfected cells can be selected with the antiboiotic G418. 
 
pmCherry-C1: Expression is driven by the human cytomegalovirus (CMV) 






pGEX-4T3: Bacterial expression is driven by the tac promoter. Amicillin resistance 
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